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ABSTRACT 
Memory impairments accompany aging and can range in severity from mild 
deficits during healthy aging to debilitating conditions such as Alzheimer’s disease. The 
causes of these impairments are generally viewed in terms of anatomical, chemical, and 
physiological changes within the brain. However, age-related changes in peripheral 
neuroendocrine systems can alter central neurobiological processes and may underlie 
some types of memory deficits. Previous work in rodents and humans indicates that 
increases in blood glucose in response to endogenous epinephrine release are 
important for regulating memory formation and durability. In old rats, glucose is less 
responsive to epinephrine and becomes severely depleted in the extracellular fluid of 
the hippocampus during a cognitively demanding task, contributing to poor memory. 
Glucose supplementation restores extracellular fluid levels of glucose and reverses the 
associated memory impairments. 
The present work examines potential mechanisms by which reduced blood 
glucose responses to epinephrine may produce age-related memory impairments, with 
particular emphasis on the ability of exogenously administered epinephrine or glucose 
to attenuate deficits in memory processes. Several findings suggest fluctuations in 
glucose levels in the extracellular fluid may modulate memory processes by altering the 
release of the neurotransmitter acetylcholine, which may affect downstream processes 
important for the formation of durable memories. In particular, nicotinic acetylcholine 
receptor signaling mediates the calcium-dependent activation of the ERK/MAPK and 
CREB signaling cascades, which are widely implicated in activity-dependent neuronal 
plasticity. Age-related deficits in brain glucose availability may limit these cholinergic 
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signaling processes and produce memory impairments. This is the major hypothesis 
guiding these studies. 
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CHAPTER 1: BACKGROUND AND SIGNIFICANCE 
1.1. AGE-RELATED FORGETTING 
In humans, memory impairments accompany healthy aging as well as various 
age-related pathologies, which can range in severity from Mild Cognitive Impairment to 
debilitating conditions such as Alzheimer’s disease. A variety of age-related memory 
impairments manifest as the rapid forgetting of recent information and events, with older 
memories remaining intact (Craik, 1994; MacDonald et al., 2006; Munro Cullum et al., 
1990; Park et al., 1988; Wheeler, 2000). Age-related rapid forgetting may develop 
gradually throughout the lifespan and is task-dependent, with certain types of 
information more susceptible than others. For example, tests of free recall of word lists, 
verbal passages, and pictures are much more sensitive to aging effects than those 
involving only recognition of previously encountered items. Age-related forgetting is also 
particularly evident in tests of spatial navigation and working memory tasks. In most of 
these tasks, forgetting is evident even when learning is matched between young and old 
subjects, indicating that forgetting does not erroneously reflect age-related differences 
in attention or acquisition. 
Similar findings of accelerated forgetting have been reported in rats and mice, 
with specific time courses that differ by age and task (Barnes, 1979; Barnes and 
McNaughton, 1985; Gold, 2005; Korol, 2002; Winocur, 1988). For example, a commonly 
used rodent model of age-related forgetting is inhibitory avoidance training. In this task, 
a rodent is placed into a small box illuminated by a bright light and is allowed to cross 
over freely into a dark chamber, where it receives a foot shock. At a later time, usually 
several hours or days later, the rodent is again placed into the light chamber and its 
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testing retention latency to cross over into the dark chamber is recorded. The testing 
retention latency is taken as a measure of memory for receiving the foot shock, with 
longer latencies indicating good memory and shorter latencies indicating forgetting. In 
young adult rats, memory for inhibitory avoidance training is stable for up to three weeks 
following a brief, mild foot shock. However, old rats exhibit slight deficits after one day, 
and are significantly impaired after seven days. These results cannot be explained by a 
lower sensitivity to the foot shock in old compared to young rats, as old rats have similar 
perceptual thresholds as young rats for the same foot shock and have comparable or 
even better memory than young rats when tested two hours after training. Thus, old rats 
exhibit rapid forgetting for inhibitory avoidance, with memory intact for hours after 
training, but with memory impairments emerging during the days after training (Gold et 
al., 1982). A major advantage of inhibitory avoidance training is that it tests memory 
after a single learning trial, thus eliminating confounds due to multiple trials. Another 
advantage is drugs that modulate memory formation can be administered post-training, 
eliminating the effects of these drugs on perception, motivation, or other factors that 
might alter learning instead of memory. 
Another good model of age-related forgetting is the spontaneous alternation 
task—a test of spatial working memory. In this task, a rodent is allowed to freely 
traverse a three- or four-arm maze in a room containing a variety of spatial cues. A 
rodent with good spatial memory will tend to visit arms it has not recently visited. This 
tendency can be quantified and compared to chance performance on the task. For 
example, in the four-arm maze, visiting each of the four arms in overlapping sets of five 
attempts constitutes an alternation. Young adult rats trained on this task generally have 
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average alternation scores between 55% and 65%, which is significantly better than 
chance performance (44%). Though old rats visit similar numbers of arms as young 
rats, their alternation scores are at or near chance performance, indicating significant 
age-related forgetting (McNay and Gold, 2001). Increasing task difficulty by instituting a 
delay between arm entries impairs performance in young adult and middle-aged 
rodents, which is useful for modeling aging effects (e.g. Stone et al., 1997). In contrast, 
reducing task difficulty by utilizing a three-arm instead of a four-arm maze attenuates 
age-related impairments (McNay and Gold, 2001). Spontaneous alternation training has 
an advantage over similar tasks because it is non-appetitive and does not require 
associated rewards (food, water) or punishments (e.g. foot shock, immersion in water) 
to motivate performance. 
The present studies utilize both inhibitory avoidance and spontaneous alternation 
training to model age-related forgetting. Besides these tasks, rodents exhibit age-
related forgetting in a variety of other tasks, including the water maze (Burke et al., 
2008; Gage et al., 1984; Mabry et al., 1996; Rapp et al., 1987), reward reduction 
(Salinas and Gold, 2005), social transmission of food preference (Countryman and 
Gold, 2007), visual discriminated avoidance (Gold et al., 1982), Barnes circular maze 
(Barnes and McNaughton, 1985), spatial reversal (Zornetzer et al., 1982), odor-reward 
association (Roman et al., 1996), and eye-blink classical conditioning (e.g. Solomon et 
al., 1995; Woodruff-Pak et al., 2007). Thus, rapid forgetting is a key characteristic of 
age-related memory impairments. 
Previous work in rodents suggests rapid forgetting may reflect deficits in 
neurobiological mechanisms of memory formation initiated during or soon after training. 
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For example, old rodents have training-related alterations in neurotransmitter release, 
calcium signaling, and gene expression within the brain, all of which may be interrelated 
and contribute to memory impairments (Burke and Barnes, 2006; Dickstein et al., 2007; 
Kelly et al., 2006; Mora et al., 2007; Toescu and Verkhratsky, 2007; Yankner et al., 
2008). These age-related alterations do not all necessarily reflect intrinsic deficits in 
brain function, but may originate from changes in peripheral processes. A variety of 
evidence suggests that changes in peripheral hormones and neuroendocrine systems 
during aging can alter central neurobiological processes, producing deficits in memory 
and synaptic plasticity (Conrad and Bimonte-Nelson, 2010; Foy, 2011; Frick, 2009; 
Janowsky, 2006; Korol and Gold, 2007; Lupien et al., 2009). 
 
1.2. EPINEPHRINE, GLUCOSE, AND RAPID FORGETTING 
Of particular relevance to the work presented here, numerous studies suggest 
that deficits in blood glucose responses to epinephrine during and after training may 
contribute to age-related impairments in memory processes (Gold, 2005; Korol, 2002; 
Korol and Gold, 1998; Messier, 2004). In non-aged populations, the pathway through 
which glucose modulates memory processes in response to endogenous epinephrine 
release is one of the most extensively studied neuroendocrine systems involved in 
learning and memory (Gold, 1995, 2008; Gold and Korol, 2010; Korol and Gold, 2007; 
Messier, 2004). Epinephrine, which is released from the adrenal medulla in response to 
emotional or stressful events, enhances memory for a variety of tasks in both rodents 
and humans. The enhancement follows an inverted-U dose-response curve in which 
moderate doses of epinephrine enhance memory and high doses impair memory. 
Likewise, epinephrine enhances the duration of long-term potentiation (LTP), which is 
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widely considered to be an analog of memory, from minutes to at least several days, 
following a similar inverted-U dose-response curve (Korol and Gold, 2008). Since 
epinephrine does not readily cross the blood brain barrier, the hormone most likely 
enhances memory by engaging peripheral mechanisms that modify brain functions. Two 
major mechanisms have been examined for how epinephrine enhances central memory 
processes. One mechanism proposes that epinephrine activates vagal afferents 
projecting to the nucleus of the solitary tract (NTS). Adrenergic activation of NTS 
neurons, in turn, potentiates release of norepinephrine in the amygdala and enhances 
performance in emotionally arousing tasks (McGaugh, 2004; McGaugh and 
Roozendaal, 2002; McGaugh et al., 2002). Another mechanism, which is the major 
focus of the present work, proposes that glucose is a major intermediary of the effects 
of epinephrine on memory. Glucose is released from liver glycogen stores in response 
to circulating epinephrine. Like epinephrine, peripheral injections of glucose enhance 
memory in rodents and humans, also following an inverted-U dose-response curve. 
Peripheral adrenergic receptor antagonists block the memory-enhancing effects of 
epinephrine injections (Sternberg et al., 1985, 1986) but not of glucose (Gold et al., 
1986), supporting the view that glucose bypasses this step in the memory enhancement 
pathway. Moreover, direct infusions of glucose into the lateral ventricles or into specific 
brain areas, including the medial septum, hippocampus, and amygdala, enhance 
memory, which is consistent with the idea that glucose acts directly on brain 
mechanisms of memory (Gold, 2005). Thus, the efficacy of direct brain glucose 
injections in enhancing memory supports the view that blood glucose modulates 
memory processes by regulating brain glucose levels. 
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 Prior work indicates there are age-related declines in blood glucose responses to 
epinephrine, which may contribute to memory impairments by limiting the supply of 
glucose to the brain during cognitively demanding times (cf. Gold, 2005). Studies by 
Mabry et al. (1995a,b,c) indicate that plasma epinephrine levels increase more in old 
compared to young rats in response to acute swim stress, chronic restraint stress, and 
foot shock. In contrast, plasma glucose levels increased in young but not old rats shortly 
after foot shock (Mabry et al., 1995c). Thus, endogenous epinephrine release in 
response to foot shock has little effect on blood glucose levels in old rats. Other studies 
have shown that regional fluctuations in brain glucose concentrations in the extracellular 
fluid are important in memory processing, and that these fluctuations have important 
consequences during aging. When rats perform a spontaneous alternation task, the 
levels of extracellular glucose in the hippocampus decrease significantly. Systemic 
injections of glucose block this decrease and enhance memory for the task (McNay et 
al., 2000). This suggests there is a limited supply of glucose to be taken up and utilized 
by hippocampal cells in support of memory processes. Aged rats exhibit significantly 
greater forgetting combined with a much larger and longer duration of reduction in 
extracellular glucose levels compared to young rats. The more rapid recovery of brain 
glucose levels in young rats is associated with a rise in blood glucose levels, which is 
absent in aged rats. Of particular interest, peripheral injections of glucose reverse the 
age-related depletion of hippocampal glucose and improve memory scores of aged rats 
to those of young rats (McNay and Gold, 2001). Together, these results indicate that 
age-related declines in blood glucose rises in response to training/epinephrine may 
cause large reductions in hippocampal glucose and associated memory impairments. 
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Age-related deficits in glucose availability within the brain may contribute to 
memory impairments through a variety of mechanisms. Glucose utilization by the 
pancreas provides one model for how glucose may function in the brain and how 
deficits in central glucose availability may produce memory impairments. Pancreatic 
islet cells have a large number of ATP-dependent potassium (K-ATP) channels that are 
sensitive to subtle changes in the ATP/ADP ratio. Increased glucose metabolism due to 
higher extracellular glucose increases the ATP/ADP ratio, facilitating membrane 
depolarization by closing of K-ATP channels. Membrane depolarization promotes 
activation of voltage-dependent calcium channels. The resulting influx of calcium into 
the cell is the main trigger for insulin release, which ultimately reduces blood glucose 
levels (MacDonald and Wheeler, 2003). Increases in intracellular calcium levels also 
lead to activation of a variety of calcium-mediated signaling pathways, altering gene 
expression and promoting islet cell proliferation and survival. The protein CREB 
regulated transcriptional coactivator 2 (CRTC2) is an important mediator of these 
changes in gene expression (Jansson et al., 2008; Screaton et al., 2004). 
Similar to the pancreas, the brain contains a large number of K-ATP channels 
that are responsive to local variations in extracellular glucose levels. K-ATP channels in 
the brain likely modulate the release of neurotransmitters and promote changes in gene 
expression through calcium-dependent mechanisms. A number of studies indicate K-
ATP channel blockers promote memory processes and may mediate the effects of 
glucose on memory enhancement (Ghelardinia et al., 1998; Rashidy-Pour, 2001; 
Stefani and Gold, 1998, 2001; Stefani et al., 1999). There are several different CRTCs 
expressed in the brain, and CRTC1 is important in the generation of hippocampal LTP 
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(Alberini, 2009; Kovacs et al., 2007; Wu et al., 2007). Together, these results suggest 
that age-related deficits in glucose supply to the brain may inhibit the ability of glucose 
to regulate neural excitability and modulate molecular memory processes through 
actions at K-ATP channels. Although this is an intriguing possibility, there are some 
inconsistencies regarding the role of K-ATP channels in glucose-mediated memory 
formation. Stefani and Gold (2001) found that the K-ATP channel opener lemakalim 
impaired, whereas the K-ATP blocker glibenclamide improved, spontaneous alternation 
performance, as predicted. However, both lemakalim and glibenclamide enhanced 
hippocampal acetylcholine output, indicating a dissociation between K-ATP channel 
modulators on memory and acetylcholine release. As will be discussed below, 
acetylcholine is thought to be a major mediator of glucose’s effects on memory 
processes. This discrepancy suggests that modulation of K-ATP channels initiates 
mechanisms parallel to or downstream of acetycholine’s effects on memory processes. 
Besides working through K-ATP channels, glucose may modulate other 
neurochemical or cellular processes important for memory enhancement. Dash et al. 
(2006) implicated the mammalian target of rapamycin (mTOR) signaling cascade, 
showing that direct glucose administration into the dorsal hippocampus improved 
memory in the water maze task while activating downstream markers of mTOR activity. 
Further, glucose failed to reverse memory impairments induced by intrahippocampal 
rapamycin. However, a major problem with the Dash study is that rapamycin 
administration obliterated phosphorylation of several proteins involved in the mTOR 
signaling cascade, reducing their expression well below basal levels. Thus, rapamycin 
may have impaired memory by altering normal cellular functions rather than by simply 
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inhibiting training-initiated cell signaling processes. In addition, although glucose 
activated proteins in the mTOR pathway, it had no effect on activation of mTOR itself. 
 
1.3. GLUCOSE MODULATION OF ACETYLCHOLINE 
Perhaps the most widely studied mechanism for glucose’s effects on memory 
processes, which is not necessarily mutually exclusive of those mechanisms already 
discussed, is through modulation of the neurotransmitter acetylcholine. Acetylcholine is 
widely implicated in learning and memory processes, activating a wide range of 
signaling pathways that are responsive to diverse stimuli. One of the most consistent 
findings in aging and age-related memory pathologies is alterations or reductions in 
cholinergic signaling processes (Bartus, 2000; Schliebs and Arendt, 2011; Terry and 
Buccafusco, 2003). These deficits are most evident in later stages of Alzheimer’s 
disease, in which there is clear degeneration in cholinergic neurons in the basal 
forebrain. However, there is a general preservation in cholinergic cells during normal 
aging, Mild Cognitive Impairment, and early stages of Alzheimer’s disease. In these 
cases, impairments in cholinergic function are evident by alterations in acetylcholine 
release, high-affinity choline uptake, nicotinic acetylcholine receptor expression, and 
neurotrophic support. 
A wide range of evidence in rodents suggests glucose enhances memory 
processes by increasing the synthesis and release of the neurotransmitter 
acetylcholine. Glucose may enhance acetylcholine by providing energy or substrates for 
a number of cellular processes, including production of acetyl-CoA, sodium-dependent 
choline uptake, and transport of acetylcholine into vesicles. Glucose may also enhance 
acetylcholine release independent of acetylcholine synthesis by modulating stimulation-
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secretion coupling in neurons. Early evidence that glucose may enhance acetylcholine 
synthesis came from studies showing that peripheral glucose administration could 
increase high-affinity choline uptake in the hippocampus of mice (Micheau et al., 1995; 
Messier et al., 1990). Other studies utilized in vivo microdialysis techniques in rats to 
directly measure acetylcholine release following glucose administration. Several of 
these microdialysis studies found that glucose could potentiate enhancements or 
attenuate reductions in acetylcholine release produced by pharmacological agents, 
such as scopolamine, morphine, and muscimol (Degroot et al., 2003; Durkin et al., 
1992; Ragozzino et al., 1994b). 
A number of microdialysis studies monitored the effects of glucose on 
acetylcholine release while rodents were engaged in behavioral memory tasks. In a 
study by Kopf et al. (2001), the authors found that low intraperitoneal doses of glucose 
plus choline in mice acted synergistically to improve retention latencies for inhibitory 
avoidance, while enhancing hippocampal acetylcholine release. Ragozzino et al. 
performed a series of microdialysis studies in rats utilizing the spontaneous alternation 
working memory task. Ragozzino and Gold (1995) found that concomitant injections of 
glucose with intraseptal morphine reversed morphine-induced deficits in acetylcholine 
release and working memory. Later, Ragozzino et al. (1996, 1998) showed that both 
intraperitoneal and direct intrahippocampal injections of glucose enhanced hippocampal 
acetylcholine release while improving spontaneous alternation performance. 
Interestingly, Ragozzino et al. (1998) found that unilateral injections of glucose into the 
hippocampus enhanced acetylcholine release both ipsalateral and contralateral to the 
injection site, suggesting that glucose may promote communication between 
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hippocampal hemispheres through feedback to the medial septum or by some other 
mechanism. 
Importantly, glucose enhances acetylcholine release only under conditions of 
training or pharmacological manipulation, but not while animals are at rest, indicating 
glucose is a modulator of acetylcholine activity (Degroot et al., 2003; Durkin et al., 1992; 
Kopf et al., 2001; Messier et al., 1990; Ragozzino et al., 1996, 1998). Thus, there are 
likely regional variations in glucose-mediated acetylcholine release, depending on task 
demands, which may promote signaling through specific acetylcholine receptor types. 
To examine this possibility, a number of behavioral studies have administered glucose 
peripherally in combination with an antagonist for muscarinic or nicotinic receptors, 
which are the two major acetylcholine receptor types in the brain. Glucose attenuated or 
completely reversed antagonist-induced behavioral deficits in a variety of tasks, 
including spontaneous alternation, inhibitory avoidance, radial arm maze, and 
exploration of a novel environment (Blanchard and Duncan, 1997; Kopf and Baratti, 
1994; Ragozzino and Gold, 1991; Ragozzino et al., 1994a; Stone et al., 1988, 1991, 
1995). In one case, glucose reversed deficits in the spontaneous alternation task 
following co-administration of subthreshold doses of a nicotinic and muscarinic 
antagonist (Ragozzino et al., 1994a). Although the results of these studies suggest 
glucose does not work through any specific acetylcholine receptor type, the findings are 
open to a large number of interpretations. For example, consider the case in which 
glucose reversed spontaneous alternation deficits caused by mecamylamine, a general 
nicotinic receptor antagonist (Ragozzino and Gold, 1991). In this case, glucose may 
have improved task performance by enhancing acetylcholine release, which (a) 
 12 
activated unblocked muscarinic receptors; (b) outcompeted mecamylamine for nicotinic 
binding sites; and/or (c) activated nicotinic receptors that have a low affinity for 
mecamylamine. Glucose may have also enhanced the release of other 
neurotransmitters or facilitated other memory processes. In addition, mecamylamine is 
known to affect a variety of processes not specific to memory, such as attention and 
locomotion. Glucose may have improved behavioral performance by reversing these 
non-specific effects of mecamylamine. Thus, based on these experiments alone, it is 
difficult to determine if glucose may be promoting signaling through any specific 
acetylcholine receptor type. 
The established link between glucose and acetylcholine in modulating memory 
processes suggests age-related deficits in glucose availability may inhibit acetylcholine 
synthesis and release. These acetylcholine deficits may impair signaling processes 
through muscarinic and nicotinic receptors, thus causing or contributing to age-related 
memory impairments. Indeed, a major reason cholinergic neurons are more susceptible 
to pathological aging processes may be because of their high dependence on glucose 
metabolism for both energy production and synthesis of acetyl-CoA, a key substrate in 
acetylcholine synthesis (Hoyer, 2000; Meier-Ruge et al., 1994). 
 
1.4. ACETYLCHOLINE RECEPTORS IN AGING AND MEMORY PROCESSES 
Acetylcholine activates both muscarinic and nicotinic signaling processes in the 
brain. Muscarinic acetylcholine receptors are G protein-coupled receptors widely 
distributed throughout human and rodent brains. There are five major subtypes of 
muscarinic receptors in the brain, designated M1 through M5. M1 receptors are the most 
abundant subtype. M1 receptors also have the highest expression in brain regions that 
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exhibit known age- or pathology-related reductions in cholinergic function or innervation 
(Ehlert et al., 1995; Levey et al., 1991; Wevers, 2011). In addition, M1 receptors do not 
show major reductions or changes in distribution with aging or age-related pathologies. 
Thus, M1 receptors have become a target for enhancing cognition in Alzheimer’s 
disease and age-related memory decline. However, the efficacy of M1 receptor agonists 
is complicated by a large number of peripheral side effects (Ehlert et al. 1995; Terry et 
al. 2011). 
A major focus of the present work is on nicotinic acetylcholine receptors, which 
play an important role in learning and memory processes and are one of the most 
promising current drug targets for enhancing cognition in neuropsychiatric and 
neurological disorders (Cincotta et al., 2008; Kenney and Gould, 2008; Levin et al., 
2006; Picciotto and Zoli, 2002; Terry et al. 2011). Neuronal nicotinic receptors are 
ionotropic receptors that are found both pre- and post-synaptically. At pre-synaptic sites, 
nicotinic receptors regulate the release of neurotransmitters, such as GABA, glutamate, 
and norepinephrine. Post-synaptically, nicotinic receptors function in membrane 
depolarization and activation of intracellular signaling cascades. Nicotinic receptors are 
composed of various combinations of five membrane-spanning subunits. Nine α (α2–
α10) and three β (β2–β4) subunits have been identified, making a large number of 
receptor subtype combinations possible. However, the heteromeric α4β2 and 
homomeric α7 receptor subtypes have garnered the most attention due to their high 
levels of expression in the brain and roles in a variety of learning and memory 
processes. α4β2 receptors are very widely distributed throughout the brain, whereas α7 
receptors are more regionally localized to the cortex, hypothalamus, and limbic regions, 
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such as the hippocampus and amygdala (Dominguez del Toro et al., 1994; Gotti and 
Clementi, 2004; Wevers, 2011). 
Nicotinic α4β2 and α7 receptors are important in a variety of learning and 
memory processes. Both α4β2 and α7-mediated signaling appear to play crucial roles in 
spatial working memory, as assessed mainly by the radial arm maze task in rodents. 
Infusions of either methyllycaconitine (MLA) or dihydrobetaerythroidine (DHβE), which 
are competitive antagonists for α7 and α4β2 receptors, respectively, into the ventral 
hippocampus, dorsal hippocampus, amygdala, or frontal cortex, impaired working 
memory in the radial arm maze (Addy et al., 2003; Bettany and Levin, 2001; Chan et al., 
2007; Levin et al., 2002; Nott and Levin, 2006). Likewise, various agonists for α7 and 
α4β2 receptors improved working memory performance in the radial arm maze (Chan et 
al., 2007; Levin et al., 1999). A more recent study found that mice with knockouts of the 
β2 or α7 subunits had significant deficits in radial arm maze testing, with some 
variations by sex (Levin et al., 2009). Although α4β2 and α7 receptors appear to 
function very similarly in the radial arm maze task, there are also some functional 
differences between these receptor subtypes. For example, there are a number of 
studies indicating a specific role for α4β2 but not α7 receptors in mediating the effects of 
nicotine on enhancing memory for contextual fear conditioning (Davis and Gould, 2006, 
2007; Davis et al., 2007; Kenney et al., 2012). Conversely, there is more evidence 
indicating a role for α7 compared to α4β2 receptors in spatial learning and memory as 
assessed in the water maze (Curzon et al., 2006; Meyer et al., 1997; Ren et al., 2007; 
Timmermann et al., 2007; Vicens et al., 2011), although direct comparisons with α4β2 
receptors are often lacking in these studies. 
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An unusual feature of α7 receptors is their particularly high permeability for 
calcium. Although α4β2 receptors are moderately permeable to calcium, differences in 
calcium permeability between α7 and α4β2 receptors may help explain some of their 
functional differences. For example, α4β2 and α7 receptors have significantly different 
and often opposing roles in regulating synaptic plasticity, especially LTP. A large 
number of studies indicate that activation of α7 receptors facilitates the induction and 
maintenance of hippocampal LTP (e.g. Biton et al., 2007; Hunter et al., 1994; Kroker et 
al., 2011; Lagostena et al., 2008; Matsuyama and Matsumoto, 2003; Matsuyama et al., 
2000; Ondrejcak et al., 2011; Söderman et al., 2011). In contrast, activation of α4β2 
receptors appears to impair the generation and have no effect on the maintenance of 
hippocampal LTP (Kroker et al., 2011; Mao et al., 2011; Wang et al., 2006; Wu et al., 
2008). Differences in calcium permeability may also help explain differences in the 
ability of α4β2 and α7 receptors to activate downstream molecular signaling pathways, 
which is discussed in more detail later. 
Like with muscarinic receptors, reduced cholinergic function or innervation in 
aging and age-related pathologies may inhibit signaling through nicotinic receptors, 
providing a potential therapeutic target. Unlike with muscarinic receptors, there is a 
general consensus that nicotinic receptors and their subunits slowly decline in numbers 
during aging, with some regional specificity. In Alzheimer’s patients, a significant 
reduction in nicotinic receptors in specific brain areas, such as the parahippocampal 
region, remains one of the most consistent markers of the disease (Gotti and Clementi, 
2004; Picciotto and Zoli, 2002; Schliebs and Arendt, 2011). In addition, neurons 
expressing high levels of nicotinic receptors, especially of the α7 subtype, may be 
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particularly vulnerable to degeneration in Alzheimer’s disease (D'Andrea and Nagele, 
2006). 
The α7 and α4β2 subtypes have been the major nicotinic receptor targets for 
enhancing cognition in aging and Alzheimer’s disease. However, much of the current 
attention is on α7 receptors agonists, which have yielded some promising results in 
clinical trials (Terry et al., 2011). The focus on α7 receptors may be due to their confined 
distribution in the brain, limiting the potential side effects of α7 agonists. In addition, 
unlike α4β2 receptors, α7 receptors do not play a major role in the addictive properties 
of nicotine (De Biasi and Dani, 2011), meaning there is less potential for abuse of drugs 
targeting α7 receptors. Pre-clinical studies suggest nicotinic agonists may compete with 
β-amyloid peptides for α7 receptor binding sites, promoting cell survival or cell death, 
respectively. This hypothesis may provide a crucial link to understanding the 
pathoetiology of Alzheimer’s disease (Buckingham et al., 2009; Jürgensen and Ferreira, 
2010; Parri et al., 2011). 
 
1.5. (ALMOST) EVERYBODY LOVES CREB 
Acetylcholine-related signaling activates a variety of downstream molecular 
memory pathways. Particularly relevant to the present studies, nicotinic agonists 
mediate the calcium-dependent activation of cAMP response element binding protein 
(CREB) in the hippocampus and other brain areas. CREB is widely implicated in the 
formation of long-lasting memories, and may provide an important downstream marker 
of cholinergic signaling processes related to memory. 
 CREB is a nuclear protein that is part of a family of transcription factors 
containing a conserved basic region-leucine zipper (bZIP) domain. CREB is activated 
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mainly by phosphorylation, which can be triggered by a variety of intracellular signaling 
processes. Phosphorylation at serine 133 is considered critical for CREB activation 
(Montminy et al., 1990). Once activated, CREB binds to regulatory sequences of DNA 
as a homodimer or as a heterodimer with another bZIP-family transcription factor, thus 
altering expression of a large number of downstream genes. The specific set of genes 
regulated by CREB is determined by many factors, including the cell type, site(s) of 
phosphorylation, dimerization properties, and interactions with co-activators and other 
regulatory proteins (Shaywitz and Greenberg, 1999; Alberini, 2009). 
CREB is a ubiquitous protein involved in a wide variety of brain processes, 
including cell survival, neurogenesis, addiction, depression, synaptic plasticity, and 
memory (Alberini, 2009; Blendy, 2006; Carlezon et al., 2005; Merz et al., 2011; 
Persengiev and Green, 2003; Robison and Nestler, 2011). However, neuronal CREB is 
best known for its role in memory processes, where it is believed to initiate changes in 
gene expression that convert short-term memory and short-term alterations in synaptic 
plasticity to more permanent and durable forms (Alberini, 2009; Benito and Barco, 2010; 
Carlezon et al., 2005; Lee et al., 2008; Silva et al., 1998; Yin and Tully, 1996). 
Electrophysiological studies in Aplysia and studies of olfactory memory in Drosophila 
provided early evidence that CREB may play an evolutionarily conserved role in 
memory formation. Soon after, the two major isoforms of CREB with the highest 
expression in the brain were genetically knocked out in mice. These CREB mutant mice 
were surprisingly viable given the involvement of CREB in development. However, they 
had deficits in a variety of hippocampal-dependent memory tasks, including contextual 
fear conditioning, water maze, and social transmission of food preference 
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(Bourtchuladze et al., 1994; Kogan et al., 1997). These effects on memory were 
generally limited to long but not short training-testing intervals (although see discussion 
below). 
The early CREB studies provided the groundwork for numerous other 
investigations of CREB function in memory and synaptic plasticity. An abundance of 
findings indicate that blocking CREB function in specific brain areas via mutations, 
pharmacological inhibitors, or RNA interference, impairs memory when tested at long 
but not short intervals after training (Brightwell et al., 2005, 2008; Florian et al., 2006; 
Guzowski and McGaugh, 1997; Kogan et al., 2000; Lamprecht et al., 1997; Warburton 
et al., 2005; Zhang et al., 2003). Conversely, upregulating CREB function improves 
memory in a number of tasks (Brightwell et al., 2007; Josselyn et al., 2001; Sekeres et 
al., 2010; Suzuki et al., 2011). These behavioral studies are analagous to many 
electrophysiological studies suggesting that CREB is involved in the late but not early 
phase of LTP (Barco et al., 2002; Bourtchuladze et al., 1994; Davis et al., 2000; Jancic 
et al., 2009). 
A number of behavioral studies have shown that CREB phosphorylation at serine 
133 increases in a brain region-specific and task-dependent manner after training. 
Some of these studies indicate specific time windows of CREB phosphorylation 
following training (Bernabeu et al., 1997; McLean et al., 1999; O’Connell et al., 2000). 
For example, Bernabeu et al. (1997) trained rats on a step-down inhibitory avoidance 
task and analyzed phosphorylated CREB (pCREB) expression in hippocampal area 
CA1. They found that pCREB levels increased at 0, 3, and 6 hours, but not at 0.5 or 9 
hours after training, suggesting a biphasic pattern of CREB activation. In contrast, 
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Taubenfeld et al. (1999, 2001) has shown an immediate and sustained activation of 
pCREB following inhibitory avoidance training, which persists for up to 20 hours. 
Clearly, differences in training parameters may have a profound impact on the temporal 
expression profile of pCREB activation. 
A variety of neurotransmitter- and growth factor-initiated signaling processes can 
lead to CREB activation. However, the focus here is on cholinergic mechanisms of 
CREB phosphorylation. Acetylcholine can signal through M3 muscarinic receptors to 
phosphorylate CREB, which promotes cell survival in neuroblastoma and other nerve 
cells (Greenwood and Dragunow, 2002, 2010). Acetylcholine can also phosphorylate 
CREB through nicotinic receptor signaling. Nicotine administration activates calcium-
dependent CREB phosphorylation in a variety of neuronal cell types in both in vitro and 
in vivo models (Chang and Berg, 2001; Hu et al., 2002; Nakayama et al., 2001; Pascual 
et al., 2009; Tang et al., 1998). This process is mediated by an ERK/MAPK pathway 
and is modulated by L-type voltage-dependent calcium channels. Further, nicotine-
induced CREB phosphorylation occurs through both α7 and non-α7 receptor subtypes. 
Several studies have found that specific α7 receptor agonists enhanced memory in a 
battery of cognitive tests, which correlated with increased ERK1/2 and pCREB 
activation in the brain (Bitner et al., 2007, 2010; Tietje et al., 2008). 
Although a predominantly stated view is that CREB-mediated transcription is 
required and in some cases sufficient for the formation of long-term memory and LTP, 
not everyone agrees with this interpretation. This is mainly because there are a number 
of studies in CREB knockout and mutant mice that contradict this hypothesis. Balschun 
et al. (2003) found that mice with complete deletions in all CREB isoforms in the 
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hippocampus showed only slight impairments in the water maze and no impairments in 
contextual fear conditioning, and had no deficits in the formation or maintenance of LTP 
in hippocampal area CA1. Gass et al. (1998) similarly found that two different CREB 
mutant strains had no memory-related deficits in the water maze or in a social 
transmission of food preference task, and had normal LTP in the dentate gyrus and 
area CA1 of the hippocampus. Rammes et al. (2000) found only mild impairments in 
conditioned fear and no effects on LTP in the basolateral amygdala of mice expressing 
a dominant negative form of CREB mutated at Ser133. Although, as discussed, several 
studies do indicate deficits in long-lasting memory in CREB mutant mice, these deficits 
can often be reversed by altering training procedures, administering memory-enhancing 
agents, or using a different hybrid background (Frankland et al., 2004; Graves et al., 
2002; Kogan et al., 1997). There are also examples of CREB mutations altering what 
would generally be considered short-term memory processes (Graves et al., 2002; 
Suzuki et al., 2011). Moreover, other studies indicate that specific inhibitors of CREB 
function, such as antisense oligonucleotides, or more general transcription or protein 
synthesis inhibitors, may impair memory via non-specific effects on neurotransmitters or 
other memory modulators (Canal et al. 2007, 2008; Qi and Gold, 2009; Sadowski et al., 
2011). Therefore, it is important to keep in mind that multiple parallel signaling 
mechanisms can support the formation of long-lasting memories and, if CREB is 
important for memory formation, the parallel mechanisms may compensate for memory 
deficits related to CREB dysfunction. 
 
1.6. CREB, AGING, AND MEMORY 
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 Deficits in CREB function are widely implicated in cognitive impairments 
occurring during aging and in age-related pathologies, such as Alzheimer’s disease. 
Animal studies have identified significant age-related reductions in CREB function, 
especially regarding behaviorally-induced CREB phosphorylation at serine 133. 
However, these studies primarily focus on changes in hippocampal CREB, providing 
little evidence that CREB function is altered in other brain regions. In addition, little is 
known about why age-related deficits in CREB arise, including which upstream 
activators of CREB function may be impaired. 
 Investigations of hippocampal total CREB levels in old rodents are mixed, with 
several studies indicating reductions and others suggesting no significant changes 
during aging (Brightwell et al., 2004; Countryman and Gold, 2007; Foster et al., 2001; 
Kudo et al., 2005; Porte et al., 2008a; Trofimiuk et al., 2010). Inconsistencies among 
these studies may have resulted from differences in the strains of rats or mice or in how 
the tissues were collected and analyzed. Hippocampal pCREB levels at baseline, in the 
absence of any behavioral training, are generally lower in old compared to young 
rodents. Interestingly, age-related reductions in pCREB are region-specific and do not 
necessarily coincide with regional deficits in total CREB (Countryman and Gold, 2007; 
Kudo et al., 2005). Hattiangady et al. (2005) suggested that baseline pCREB levels in 
the hippocampus begin declining as early as middle age. However, one study found no 
reductions in baseline pCREB in areas CA1, CA3, or the dentate gyrus of aged mice 
(Porte et al., 2008a). Since many studies only measure pCREB responses to training or 
only present pCREB data normalized to total CREB levels, it is often difficult to gauge 
age-related differences in baseline pCREB levels. 
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 One consistent finding is that aged animals are impaired in their ability to activate 
pCREB in response to behavioral or sensory stimuli (Countryman and Gold, 2007; Kudo 
et al., 2005; Monti et al., 2005; Porte et al., 2008a; Zhang et al., 1996; Zhao et al., 
2009). Further, age-related deficits in hippocampal pCREB activation often correlate 
with memory impairments, as assessed in a variety of behavioral tasks. Deficits in 
pCREB activation occur following training in social transmission of food preference 
(Countryman and Gold, 2007), fear conditioning (Monti et al., 2005), step-down 
inhibitory avoidance (Zhao et al., 2009), and the water maze (Porte et al., 2008a; Zhao 
et al., 2009). A number of recent experiments have examined substances, such as 
green tea, ginsenoside, and St. John’s wort, that may reverse age-related deficits in 
pCREB in concert with memory enhancement (Li et al., 2009; Trofimiuk et al., 2010; Xu 
et al., 2010; Zhao et al., 2009). Although these studies do show improvements in both 
behavioral performance and pCREB activation in old rodents, these results are not likely 
specific to memory processes, since the compounds are often administered for several 
weeks or months prior to training. Thus, more work is needed to determine how various 
pharmacology-based methods of memory enhancement interact with CREB-mediated 
signaling processes. Using a non-pharmacological approach, Aguiar et al. (2011) 
examined if short bouts of exercise over five weeks in aged Wistar rats could improve 
memory while enhancing hippocampal markers of synaptic plasticity. They found that 
the exercise group, compared to age-matched controls, had better memory in a step-
down inhibitory avoidance task and water maze, and improved hippocampal pCREB 
and BDNF expression. 
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 A number of labs have attempted to improve CREB function during aging using 
transgenic mice. In a longitudinal study, Mouravlev et al. (2006) used somatic gene 
transfer of CREB or inducible cAMP early repressor (ICER) to modify hippocampal 
CREB expression in young adult rats. At 15-months of age, the CREB-transduced rats 
had better memory than similarly aged controls, as assessed by the Barnes circular 
maze and inhibitory avoidance paradigms. In contrast, the ICER-transduced rats had 
significant memory deficits, even more so than in the age-matched controls. Likewise, 
other transgenic mouse models in which CREB function is enhanced throughout much 
of the lifespan exhibit improved memory during aging (Fukushima et al., 2008; Xing et 
al., 2010). However, in contrast to these longitudinal studies, a recent experiment 
showed that viral-mediated overexpression of CREB into the hippocampus improved 
spatial memory in young adult but not middle-aged rats, suggesting that middle-aged 
rats may have deficits in upstream activators of CREB phosphorylation (East et al., 
2011). 
 CREB function is dysregulated in several human age-related neurodegenerative 
diseases, including Alzheimer’s disease and Huntington’s disease. Recently, there has 
been a renewed interest in examining CREB dysfunction in Alzheimer’s disease, with 
particular focus on how β-amyloid peptides may alter or disrupt CREB-mediated 
signaling processes. In addition, several classes of drugs that enhance CREB function, 
including nicotinic α7 receptor agonists are currently in development for treating 
cognitive impairments in Alzheimer’s disease (Bitner, 2011; De Felice et al., 2007; 
Saura and Valero, 2011; Wang and Bibb, 2011). 
 
1.7. OBJECTIVES 
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 The review of the research literature in the preceding sections illuminates a 
potential neuroendocrine pathway by which emotional events lead to memory 
enhancement in young adult animals (Figure 1.1). In old animals, a deficit in peripheral 
glucose release early in this pathway may result in impairments in all subsequent steps, 
thus leading to rapid forgetting instead of memory facilitation (Figure 1.2). In particular, 
deficits in peripheral glucose release may lead to impairments in acetylcholine release, 
nicotinic acetylcholine receptor signaling, and CREB phosphorylation, thus producing 
age-related memory impairments. This is the overarching hypothesis guiding the 
present work. 
The main objective of the present studies is to examine how an age-related 
uncoupling between peripheral epinephrine and glucose release may impair 
downstream memory processes, particularly those related to cholinergic signaling. The 
experiments in Chapter 2 examine if a dysfunction in the blood glucose response to 
circulating epinephrine contributes to age-related impairments in memory and 
hippocampal acetylcholine release. The work in Chapter 3 examines the relationship of 
CREB and pCREB to the formation of long-lasting memory in young and old rats. The 
studies in Chapter 4 attempt to determine the effects of peripheral epinephrine and 
glucose administration on memory and CREB activation in young and old rats. An 
additional goal in Chapter 4 is to determine if direct intrahippocampal administration of 
glucose can reverse age-related memory impairments. Finally, the experiments in 
Chapter 5 utilize nicotinic acetylcholine receptor antagonists in young rats to model age-
related memory impairments, investigating the relationship among glucose, nicotinic 
acetylcholine receptors, and memory. 
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1.8. FIGURES 
 
 
Figure 1.1. Model for memory enhancement by epinephrine. 
In young adult animals, emotional or stressful events induce epinephrine release from the 
adrenal medulla. Epinephrine binds to hepatic adrenergic receptors and stimulates the release 
of glucose into the blood. Glucose enhances cholinergic signaling in the brain, activating 
markers of synaptic plasticity and improving memory for the events.  
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Figure 1.2. Model for age-related forgetting. 
In old animals, there is an uncoupling between peripheral epinephrine and blood glucose. This 
uncoupling leads to impairments in downstream memory processes. 
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CHAPTER 2: AGE-RELATED MEMORY IMPAIRMENTS DUE TO REDUCED BLOOD 
GLUCOSE RESPONSES TO EPINEPHRINE1 
Increases in blood glucose levels are an important component of the mechanisms 
by which epinephrine enhances memory formation. The present experiments addressed 
the hypothesis that a dysfunction in the blood glucose response to circulating 
epinephrine contributes to age-related memory impairments. Doses of epinephrine and 
glucagon that significantly increased blood glucose levels in young adult rats were far 
less effective at doing so in 2-year-old rats. In young rats, epinephrine and glucose were 
about equally effective in enhancing memory and in prolonging post-training release of 
acetylcholine in the hippocampus. However, glucose was more effective than 
epinephrine in enhancing both memory and acetylcholine release in aged rats. These 
results suggest that an uncoupling between circulating epinephrine and glucose levels 
in old rats may lead to an age-related reduction in the provision of glucose to the brain 
during training. This in turn may contribute to age-related changes in memory and 
neural plasticity. 
 
2.1. INTRODUCTION 
 Epinephrine, released from the adrenal medulla in response to many 
experiences, enhances memory in both rodents and humans (Cahill and Alkire, 2003; 
Gold, 2001, 2005; Gold and McCarty, 1995; Gold and McGaugh, 1975; Gold and van 
Buskirk, 1975; Korol and Gold, 2007; McGaugh and Roozendaal, 2002). Because 
                                                             
1 This chapter appeared in its entirety in the journal Neurobiology of Aging and is referred to later in this 
dissertation as Morris et al., 2010. Morris, K.A., Chang, Q., Mohler, E.G., and Gold, P.E. (2010). Age-related memory 
impairments due to reduced blood glucose responses to epinephrine. Neurobiol. Aging, 31, 2136-2145. This article 
is reprinted with the permission of the publisher. 
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epinephrine does not readily cross the blood–brain barrier, the hormone most likely 
enhances memory by engaging peripheral mechanisms that modify brain functions. 
Glucose, released from the liver in response to circulating epinephrine, enhances 
memory, with results similar to epinephrine (Gold, 1995, 2005; Korol and Gold, 2007; 
McNay and Gold, 2002; Messier, 2004). However, some important differences between 
the two treatments support the idea that increases in blood glucose mediate the effects 
of epinephrine on memory. First, peripheral adrenergic receptor antagonists block the 
memory-enhancing effects of peripheral epinephrine injections (Sternberg et al., 1986), 
but not of glucose (Gold et al., 1986), suggesting that glucose bypasses the need to 
activate peripheral adrenergic receptors to enhance memory. Second, glucose 
enhances memory in food-deprived rats but epinephrine does not (Talley et al., 2000), 
which is consistent with the diminished increases in blood glucose to epinephrine 
injections seen after food deprivation. Additionally, microinjections of glucose into the 
lateral ventricles, medial septum, hippocampus, and amygdala enhance memory (Canal 
et al., 2005; Krebs and Parent, 2005; Pych et al., 2006; Ragozzino et al., 1996, 1998; 
Schroeder and Packard, 2003). These findings are consistent with the idea that glucose 
acts directly on the brain to modulate memory processing (Gold, 2005, 2008; Korol and 
Gold, 2007). 
 There are several mechanisms by which glucose might modulate brain functions, 
including regulating neural excitability and stimulus–secretion coupling by closing 
potassium-ATP channels (Rashidi-Pour, 2001; Stefani and Gold, 2001; Stefani et al., 
1999) and regulating cell signaling mechanisms such as the mammalian target of 
rapamycin (TSC-mTOR) cascade (Dash et al., 2006). Additionally, both systemic and 
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central injections of glucose appear to act on memory through cholinergic mechanisms 
(Durkin et al., 1992; Gold, 1995; Kopf et al., 2001). In particular, in vivo microdialysis 
studies show that glucose augments training-related release of acetylcholine (ACh) in a 
manner related to enhancement of memory (cf. McNay and Gold, 2002; Ragozzino et 
al., 1996, 1998). Together with the relationships between loss of cholinergic functions 
and aging (cf. Bartus et al., 1982; Mesulam, 2004), these findings suggest a possible 
link between glucose and ACh during aging. The present experiment adds support to 
these relationships. 
 Regional fluctuations in brain glucose concentrations in extracellular fluid (ECF) 
are evident during memory testing. ECF glucose levels in the hippocampus decrease 
substantially while rats are tested on a spatial working memory task (McNay and Gold, 
2001; McNay et al., 2000). Systemic injections of glucose block this decrease when 
enhancing memory, suggesting that ECF glucose levels limit the efficacy of memory 
processing. The training-induced decreases in hippocampal ECF glucose are 
exaggerated in aged rats. Systemic administration of glucose blocks this decrease in 
ECF glucose and enhances memory, raising the scores of old rats to those of young 
rats. Blood glucose responses to behavioral testing are decreased in senescent rats, 
but circulating epinephrine responses to training or stress are actually increased (Gold, 
2005; Mabry et al., 1995a,b,c). The increase in release of epinephrine without 
subsequent increases in circulating glucose levels suggests a breakdown in a 
neuroendocrine pathway important for modulating memory in old rats, potentially at the 
step in which glucose release from the liver is coupled to the binding of epinephrine. 
The uncoupling between peripheral epinephrine and glucose release may reduce the 
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amount of glucose available to the brains of old rats during memory tasks and lead to 
the memory impairments and other cognitive changes seen in aged rats, mice and 
humans (Buckner, 2004; Chawla and Barnes, 2007; Disterhoft and Oh, 2006; Gazzaley 
and D’Esposito, 2007; Gold, 2005; Korol, 2002; Mattson et al., 2004). The present 
experiments examine the role of uncoupled epinephrine–glucose responses in 
modulation of memory and in augmenting training-related release of ACh in aged rats. 
 
2.2. MATERIALS AND METHODS 
2.2.1. Subjects 
Young adult (3–5 months) and old (24–26 months) male Fischer-344 rats from 
NIA colonies were individually housed in translucent cages with a 12-h light/dark cycle 
(lights on at 07:00 h) and ad libitum access to food and water. One set of rats was used 
for the blood glucose measurements (Figs. 2.2 and 2.3). A second set of rats was used 
for the memory and neurochemistry experiments (Figs. 2.4–2.6). 
 
2.2.2. Blood glucose measurements 
Rats were handled for 4–5 min each day for 5 consecutive days prior to blood 
glucose measurements. Epinephrine (0.1 mg/kg [Ns = 6 young, 5 old] or 0.3 mg/kg [Ns 
= 6 young, 4 old]) or glucagon (200 µg/kg or 400 µg/kg [all Ns = 4]) was injected 
subcutaneously, followed by monitoring of blood glucose levels by collecting blood 
drops from the tip of the tail with a Penlet® (Lifescan, Inc., Milpitas, CA) and measuring 
their glucose levels with a One Touch® glucometer (Lifescan, Inc., Milpitas, CA). Data 
were discarded for three old rats receiving epinephrine injections because their baseline 
blood glucose levels were markedly low. 
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2.2.3. Surgery 
Rats were anesthetized with isoflurane and placed in a stereotaxic apparatus 
with skulls in a horizontal orientation. A CMA/11 guide cannula (CMA, North 
Chelmsford, MA) was implanted above the central portion of the ventral hippocampus in 
both young [coordinates: −5.5 mm from bregma; ±4.8 mm lateral; −4.2 mm deep from 
skull] and old [coordinates: −5.8 mm from bregma; ±5.0 mm lateral; −4.8 mm deep from 
skull] rats. Skull screws were inserted and the entire assembly was anchored in place 
with dental cement. Beginning 1 week after surgery, rats were handled 4–5 min each 
day for 5 consecutive days prior to microdialysis and behavioral training. 
 
2.2.4. Microdialysis 
On the day of training, a 4-mm CMA/11 microdialysis probe (CMA) was inserted 
into the ventral hippocampus. Brains were perfused continuously at a rate of 0.67 µl/min 
with artificial cerebral spinal fluid (aCSF: 128 mM NaCl, 2.5 mM KCl, 1.3 mM CaCl2, 2.1 
mM MgCl2, 0.9 mM NaH2PO4, 2.0 mM Na2HPO4, 1.0 mM dextrose, pH 7.4) containing 
200 nM of the acetylcholinesterase inhibitor neostigmine (Chang et al., 2006). The 1.0 
mM dextrose in the aCSF was based on previous work showing that extracellular 
glucose levels in the hippocampus of awake young and aged rats are about 1.0 mM 
(McNay and Gold, 1999). Samples collected during the first hour of microdialysis were 
discarded to allow for baseline stabilization (Westerink and Timmerman, 1999). Ten 
total samples were collected in 10-min intervals immediately prior (samples B1–4), 
during (P1), and after (P2–6) training. The final volume of each sample was 6.7 µL. 
 
2.2.5. Training 
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After 4 baseline samples (10 min each) were collected, rats were trained on a 
one-trial inhibitory avoidance task. The apparatus was a trough-shaped alleyway (91 cm 
long, 22.9 cm wide at the top, 7.6 cm wide at the bottom, and 15.2 cm deep) divided 
into lit (31 cm) and dark (60 cm) compartments by a sliding door that could be lowered 
through the floor. Rats were placed in the lit chamber and the door was lowered. Upon 
entering the dark chamber, the door was closed and the rats received a brief mild 
footshock (0.2 mA, 0.4 s). To facilitate comparisons of drug enhancement of memory at 
both ages, the shock level and training conditions were selected to match 48-h memory 
across ages. Past evidence indicates that age-related differences in forgetting would 
likely be seen at longer training-test intervals (Gold et al., 1982), but this was not 
assessed here. Immediately after training, rats received a subcutaneous injection of 
saline (0.9%) (Ns = 18 young, 15 old), epinephrine (0.1 mg/kg) (Ns = 8 young, 8 old), or 
glucose (250 mg/kg) (Ns = 9 young, 7 old). The rats were then returned to the holding 
cage as microdialysis continued. Memory, measured as the latency to enter the dark 
compartment (maximum = 300 s), was assessed 48 h later. 
 
2.2.6. HPLC 
 Microdialysis samples were assayed for ACh using high performance liquid 
chromatography (HPLC) with electrochemical detection (BAS; Bioanalytical Systems, 
West Lafayette, IN). Five µl of each sample were manually injected into the system via 
an injection valve with a 10 µl loop (Rheodyne, Rohnert Park, CA). Samples were 
separated using an ion-exchange microbore analytical column (BAS P/N MF 8904, 530 
mm×1 mm) followed by a microbore ACh/choline immobilized enzyme reactor 
containing acetylcholinesterase and choline oxidase (BAS P/N MF-8903, 50 mm×1 
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mm). Electrochemical detection was performed by a 3 mm glassy fiber working 
electrode (BASP/NMF1095) coated with a redox polymer film containing horseradish 
peroxidase and an auxiliary electrode with a radial flow electrochemical thin-layer cell 
and a 13 mm thin-layer gasket (BAS P/N MF 1091). The working electrode held a 100 
mV potential relative to an Ag/AgCl reference electrode (BAS P/N MF 2078). A 
Shimadzu LC-10ADvp pump (Tokyo, Japan) with microstep plunger maintained the flow 
rate at 140 µL/min. The mobile phase contained 50 mM Na2HPO4 and 0.005% ProClin 
(BAS P/N CF-2150) and was adjusted to a pH of 8.5. Assays were completed within 
12.5 min. The detection limit of this system was approximately 5 fmol. 
 
2.2.7. Histology 
 Rats were deeply anesthetized with sodium pentobarbital prior to decapitation. 
Brains were removed and placed into 4% paraformaldehyde in 0.1M phosphate buffer 
for at least 24 h. The brains were transferred to 20% glycerol in 0.1M PB for at least 24 
h. Frozen sections (50 µM) were collected with a Leica 1800 cryostat. Sections 
containing the guide cannulae tracts were mounted on slides, dried, stained with cresyl 
violet, and visualized under a microscope (Fig. 2.1). Behavioral and chemical data were 
discarded for those rats (N= 3) with probe sites outside of the ventral hippocampus. 
 
2.2.8. Data analyses 
All analyses were performed using Statview software. Blood glucose results and 
HPLC data were analyzed using repeated measures ANOVA with post hoc Fisher 
PLSD and t-tests where appropriate. Behavioral results were analyzed using unpaired t-
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tests. Absolute levels of ACh release were calculated using recovery and internal HPLC 
standards. 
 
2.3. RESULTS 
2.3.1. Epinephrine and glucagon injections raise blood glucose levels less in old than in 
young rats 
 Fig. 2.2 shows the levels of blood glucose following subcutaneous injections of 
two different doses of epinephrine. Injections of 0.1 mg/kg epinephrine, a dose 
previously shown to enhance memory in young rats (Gold and van Buskirk, 1978a), 
produced significant increases in blood glucose levels in young rats (F(1,6) = 17.11, P < 
0.0001), with peak blood glucose levels increasing by 96% above baseline at 1 h after 
injection. In contrast, the same dose of epinephrine resulted in very modest but 
statistically significant (F(1,6) = 3.54, P < 0.05) increases in blood glucose levels in old 
rats, with peak increases of only 21% above baseline evident at 30 min after injection. 
The difference in the increases in blood glucose levels in young vs. old rats was 
statistically significant (F(1,6) = 5.62, P < 0.05). 
 In young rats, injection of a higher dose (0.3 mg/kg) of epinephrine resulted in a 
significant increase in blood glucose levels (F(1,6) = 24.18, P < 0.0001) that was 
comparable to that seen at the lower dose (F(1,6) = 0.17, P > 0.5). Peak blood glucose 
levels were evident at 1 h after injection, reaching 99% above baseline. In contrast to 
the results in young rats, the epinephrine-induced increases in blood glucose levels 
were dose-dependent in old rats. Injection of the higher dose (0.3 mg/kg) of epinephrine 
in old rats resulted in significant increases in blood glucose levels compared to the 
lower dose (F(1,6) = 7.78, P < 0.05), with peak increases of 49% above baseline evident 
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at 1 h after injection. The difference in the increases in blood glucose levels in young vs. 
old rats at the higher dose of epinephrine was not significant (F(1,6) = 1.47, P > 0.1). 
Glucagon injections in young and old rats resulted in similar but more rapid 
increases in blood glucose levels compared to epinephrine, with peak levels evident at 
15 min after injection (Fig. 2.3). At both doses and both ages, glucagon injections 
resulted in significant increases in blood glucose levels (F(1,3) = 16.53–29.34, Ps < 0.01). 
Similar to epinephrine, there was a significant effect of age at a low (200 µg/kg) but not 
a high (400 µg/kg) dose of glucagon (F(1,3) = 140.81, P < 0.0001 for low dose; F(1,3) = 
3.35, P > 0.1 for high dose). Unlike epinephrine, there was a significant effect of 
treatment in young but not old rats (F(1,3) = 14.34, P < 0.01 in young; F(1,3) = 1.87, P > 
0.1 in old). 
 
2.3.2. Glucose is more effective than epinephrine at enhancing memory in old rats 
 As shown in Fig. 2.4, post-training injections of either epinephrine or glucose 
significantly increased 48-h test latencies in the inhibitory avoidance task in young rats 
(t-tests: Ps < 0.05 for epinephrine and for glucose vs. saline). The difference in test 
latencies in rats injected with glucose and epinephrine did not differ significantly (P > 
0.05). Although both epinephrine and glucose resulted in higher memory scores in 
young rats, only glucose significantly increased latencies on the memory tests in old 
rats. In old rats receiving post-training epinephrine injections, the median latency on the 
test trials increased from 74 s in the saline controls to 159 s in the epinephrine-treated 
rats, but these latencies did not differ significantly from each other (P > 0.1). In contrast, 
old rats in the glucose group had median retention latencies at the maximum of 300 s, 
which are scores significantly higher than those of the saline controls (P < 0.05). There 
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was no significant difference in test latencies between glucose and epinephrine-treated 
old rats or between glucose-treated old rats and either epinephrine- or glucose-treated 
young rats (Ps > 0.2). 
 
2.3.3. Glucose modulates training-related release of ACh similarly in young and old rats, 
but epinephrine is more effective in young than in old rats 
 Fig. 2.5 shows the ACh results obtained with in vivo microdialysis in young and 
old rats. The baseline values shown are percent change from the mean baseline levels, 
which were obtained for each rat by averaging the 4 samples (20 min each) collected 
prior to training. Thus, the data are presented as percent change from baseline levels in 
10-min intervals immediately prior to (B1–4 = Baseline), during (P1), and after (P2–6) 
training. In both young and old rats, training in the saline-treated rats resulted in 
increases from baseline ACh release of ~100–150%, which gradually returned to 
baseline in the 40 min or so after training. In young rats, there was a significant effect of 
treatment (F(2,9) = 3.66, P < 0.05), in which post-training administration of epinephrine or 
glucose significantly enhanced ACh release (Fisher’s PLSD: Ps < 0.05 vs. saline). 
As was seen in young rats, there was a significant effect of treatment on ACh 
release (F(2,9) = 6.76, P < 0.01) in old rats, with glucose significantly enhancing ACh 
release compared to saline (P < 0.0001). However, unlike in young rats, epinephrine did 
not significantly increase ACh release in old rats (P > 0.05), although it did result in 
modest non-significant increases in the duration of ACh release. These results parallel 
those shown in Figs. 2.2 and 2.4, in which epinephrine was deficient in increasing blood 
glucose levels and in enhancing memory in old rats, respectively. 
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2.3.4. Baseline ACh release in the ventral hippocampus is lower in old than in young 
rats 
 While the percent changes in ACh release immediately after training are similar 
in young and old rats, as in Fig. 2.5, there are substantial age-related differences in 
baseline and peak levels of ACh concentrations in the dialysates. Fig. 2.6 shows the 
absolute baseline and training-induced levels of ACh release in the ventral 
hippocampus of young and old rats. Baseline levels were significantly lower in old rats 
than in young rats, with values about half those seen in young rats (t-test: P < 0.0001). 
Training-related levels of ACh release were reduced in old compared to young rats with 
post-training injections of both epinephrine and glucose (Fisher’s PLSD: Ps < 0.05). 
Thus, it is clear that the increases in concentration and duration of ACh release 
concentrations induced by glucose administered to aged rats bring the levels toward 
those of young baseline values but do not result in full amelioration of age-related 
decreases in release. 
 
2.4. DISCUSSION 
These findings suggest that dysfunctions in blood glucose responses to 
epinephrine contribute significantly to age-related memory loss. During aging, 
epinephrine develops reduced efficacy in increasing blood glucose levels, enhancing 
memory, and augmenting training-initiated increases in release of ACh in the 
hippocampus. 
 
2.4.1. Impaired blood glucose responses to epinephrine and glucagon in aged rats 
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Doses of epinephrine and glucagon that significantly increased blood glucose 
levels in young rats were far less effective at doing so in old rats, in which higher doses 
were needed to increase blood glucose levels. These findings are consistent with others 
showing that a wide variety of hormones, including insulin and ACTH, show reduced 
functionality with age (Fink et al., 1983; Giordano et al., 2001; Parker et al., 2000). 
Previous work has shown that basal levels of plasma epinephrine are similar in young 
and aged rats, but that aged rats exhibit higher circulating epinephrine levels after 
placement in a novel environment, footshock, or immersion in water (Mabry et al., 
1995a,b,c, 1996). The higher responses to stimulation may reflect a futile physiological 
attempt to generate increases in blood glucose levels. The present results support and 
extend these findings by showing that old rats have substantially blunted increases in 
blood glucose following subcutaneous injections of epinephrine. 
 In old rats, the uncoupling between circulating epinephrine and glucose suggests 
a dysfunction in the ability of the liver to produce glucose in response to epinephrine 
binding. There is substantial evidence for age-related changes in hepatic 
adrenoreceptors, including their regulation of hepatic glucose production in both rats 
and humans (Ebstein et al., 1985; Graham et al., 1987; Katz et al., 1993; Podolin et al., 
1996; Van Ermen et al., 1992). Blockade of peripheral adrenoreceptors blocks the 
effects of systemic injections of epinephrine but not glucose on blood glucose levels and 
on enhancement of memory (cf. Gold, 2005). 
The finding that blood glucose responses to both glucagon and epinephrine were 
reduced in old rats suggests involvement of shared cell signaling mechanisms beyond 
the respective receptors. Considerable evidence demonstrates age-related dysfunctions 
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in cell signaling pathways involved in hepatic glucose production, including activity of 
hepatic adenylate cyclase, involved in both epinephrine and glucagon-mediated signal 
transduction (Ebstein et al., 1985; Podolin et al., 2001), and mitochondrial damage, 
which may also be responsible for reduced rates of gluconeogenesis in hepatocytes of 
old rats (Liu et al., 2002; Sastre et al., 1996). 
 Cross-sectional studies in humans generally show a reduction in basal and 
stress-associated epinephrine in older individuals (Esler et al., 1995; Kjeldsen et al., 
1982; Seals and Esler, 2000). However, interpretation of these cross-sectional studies 
is complicated by attrition (Woodruff-Pak, 1997), a particular concern here because 
epinephrine levels are positively associated with hypertension and other conditions 
(Floras, 1992; Rand and Majewski, 1984). A relatively short-term longitudinal study of 
aging human subjects found that increases in urinary epinephrine levels in elderly 
individuals over a 3-year period were associated with declines in a variety of cognitive 
measures (Karlamangla et al., 2005). Based on this, the authors suggest that chronic 
stress may be an important predictor of cognitive decline in elderly humans. 
Alternatively, the elevated epinephrine levels may reflect disruption of a negative 
feedback mechanism due to an impaired glucose response, with cognitive impairments 
related to loss of glucose modulation of brain functions as seen in rats. 
 
2.4.2. Epinephrine and glucose effects on memory in aged rats 
A glucose dose that is effective in enhancing memory in young rats retains that 
efficacy in aged rats. However, an epinephrine dose effective in enhancing memory in 
young rats is not as effective in old rats. Together with the blood glucose results, there 
is likely an age-related shift to higher doses of epinephrine needed to enhance memory 
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in aged rats. Direct glucose injections may enhance memory in old rats by 
circumventing the functional impairment of epinephrine-induced increases in blood 
glucose levels. 
 Unlike the lower dose of epinephrine, a higher dose did significantly enhance 
circulating blood glucose in old rats. Given this, one might expect the higher dose would 
significantly enhance memory for the inhibitory avoidance task, consistent with an age-
related shift in the dose–response curve for memory facilitation by epinephrine. 
However, in attempting tests with the higher dose in aged rats, the dose resulted in 
apparent discomfort at the injection site that interfered with the behavioral tests, and the 
tests were therefore discontinued. 
 
2.4.3. Glucose effects on brain neurochemical responses to training 
Extracellular glucose levels, and the maintenance of these levels by increases in 
blood glucose levels (Fellows and Boutelle, 1993; Fellows et al., 1993; Korf et al., 
1993), appear to be important to memory functions. ECF glucose levels in the 
hippocampus decrease while rats perform a spatial working memory task; the 
magnitude of the decrease increases as a function of task difficulty (McNay et al., 
2000). Systemic injections of glucose reverse the depletion of ECF glucose and improve 
memory scores. The decrease in hippocampal ECF glucose levels is exaggerated in 
magnitude and duration in aged rats, declining by as much as 50% during memory 
testing (McNay and Gold, 2001). Of interest, the more rapid recovery of ECF glucose 
levels in young rats is associated with a rise in blood glucose levels—a rise that does 
not occur in aged rats. 
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 The effects of epinephrine–glucose uncoupling on brain functions may be 
exacerbated by other age-related dysfunctions in mechanisms of glucose uptake into 
the brain. For instance, changes with age in the efficiency and plasticity of glucose 
transporters may result in local reductions in glucose uptake (Messier, 2004; Messier 
and Teutenberg, 2005). GLUT-1 is a high-affinity glucose transporter expressed in 
capillary endothelial cells with a principle role in mediating the facilitated uptake of 
glucose through the blood–brain barrier (Maher et al., 1994). GLUT-1 is reduced in 
specific regions of the brain, including the hippocampus, during normal aging 
(Gschanes et al., 2000; Vorbrodt et al., 1999) and in Alzheimer’s disease (Horwood and 
Davies, 1994; Kalaria and Harik, 1989; Simpson et al., 1994). 
There are several mechanisms by which dynamic changes in ECF glucose might 
regulate memory functions (cf. McNay and Gold, 2002). One possibility is that ECF 
glucose may regulate neural excitability by actions at K-ATP channels. In pancreatic β-
cells, glucose controls insulin release by regulating intracellular ATP/ADP ratios and 
closing K-ATP channels (Ashcroft, 2005; Hansen, 2006). These inwardly rectifying 
potassium channels are present throughout the brain and expressed at high levels in 
the hippocampus (Dou et al., 2003; Mourre et al., 1990, 1991), offering a potential 
mechanism by which glucose might regulate neural excitability and stimulus–secretion 
coupling. Administration of drugs that close and open K-ATP channels have effects on 
memory similar to those of glucose availability and depletion, respectively (Banchelli et 
al., 2000; Ghelardini et al., 1998; Rashidi-Pour, 2001; Stefani and Gold, 2001; Stefani et 
al., 1999). 
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Changes in glucose availability, from blood glucose or by alterations in glucose 
transporter functions, have effects on neurotransmitters related to memory processing. 
Extensive evidence suggests that alterations in the cholinergic neurotransmitter system 
contribute to age-related and pathological memory impairments (Müller et al., 1991; 
Terry and Buccafusco, 2003). The finding here that baseline levels of release of ACh in 
the hippocampus decline with age is consistent with past results (Feuerstein et al., 
1992; Terry and Buccafusco, 2003; Wu et al., 1988). The augmentation of ACh release 
in aged rats by glucose did not result in full amelioration of age-related declines in 
release even as the enhancement of memory was as robust, or more so, in aged rats. 
Together, the behavioral and neurochemical findings may reflect actions of glucose on 
neural functions other than ACh release or up-regulation of receptor and cell signaling 
responses to ACh in response to the decreased levels of release. 
 While past reports showed that glucose treatment can augment ACh release 
during memory testing (Ragozzino et al., 1996, 1998), the present study is the first to 
demonstrate an effect of a post-training memory-enhancing treatment on 
neurotransmitter release after an experience. Glucose was effective at augmenting 
training-related increases in the duration of ACh release in both young and old rats, in 
concert with enhancement of memory. Epinephrine also augmented the duration of ACh 
release and enhanced memory in young rats but, in contrast to glucose, failed to do so 
significantly in aged rats. 
 
2.5. CONCLUSIONS 
 The findings of these experiments support the hypothesis that age-related 
memory impairments may arise from disruptions in the neuroendocrine regulators that 
 43 
engage central memory processes. According to this view, the release of epinephrine 
and the subsequent elevation in blood glucose levels provide a crucial component of a 
process that upregulates brain mechanisms responsible for the formation of new 
memories. In young rats, trivial events accompanied by small physiological responses 
are quickly forgotten. Salient events that induce a relatively large physiological response 
lead to more enduring memories (Gold and McGaugh, 1975). The results here indicate 
that in aged rats, many experiences may be handled as ―trivial‖ events, due to an 
impaired glucose response, and are therefore forgotten more quickly. Thus, the more 
rapid forgetting observed in old rats may reflect a chain of events, beginning with an 
uncoupling of the epinephrine and glucose response as a component of dysfunctions 
leading to deficiencies in ECF glucose levels. In turn, this deficit may depress neural 
excitability and release of neurotransmitters including ACh, ultimately negatively 
impacting memory formation and maintenance. It will be important to extend these 
findings by examining the effects of treatments that enhance cognitive and other brain 
function during aging, including caloric restriction (e.g.: Adams et al., 2008; Fontan-
Lozano et al., 2007; Patel and Finch, 2002) and exercise (e.g.: Erickson et al., 2007; 
van Praag et al., 2005), on central and peripheral regulation of glucose levels and 
utilization. 
 
2.6. FIGURES 
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Figure 2.1. Cannula placement into the ventral hippocampus. 
(Left) Illustration of the area targeted in this study, showing insertion of a CMA microdialysis 
probe into the ventral hippocampus (adapted from Paxinos and Watson, 2005, Figure 80). 
(Right) Photomicrograph of a cresyl violet-stained section showing a representative cannula 
placement in the ventral hippocampus of an old rat. Scale bar = 1.6 mm. 
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Figure 2.2. Blood glucose measurements following 
injections of epinephrine. 
Age-related impairments in blood glucose responses 
were observed following a lower but not a higher 
dose of epinephrine. 
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Figure 2.3. Blood glucose measurements following 
injections of glucagon. 
Similar to epinephrine, age-related impairments in 
blood glucose responses were observed following 
a lower but not a higher dose of glucagon. 
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Figure 2.4. Age-related differences in epinephrine- and 
glucose-mediated memory enhancement. 
Effects of post-training injections of epinephrine (0.1 
mg/kg) and glucose (250 mg/kg) on memory tested 48 h 
after inhibitory avoidance training in young and old rats. 
Post-training injections of glucose, but not epinephrine, 
significantly enhanced memory in old rats. (*) Ps < 0.05 
vs. saline controls. 
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Figure 2.5. Age-related differences in modulation of acetylcholine release. 
Percent changes in ACh release in the ventral hippocampus accompanying inhibitory avoidance 
training in young (left graph) and old (right graph) rats. Compared to saline controls, post-
training injections of glucose, but not epinephrine, significantly enhanced training-related 
release of ACh in old rats (P < 0.05). B= baseline samples; P = post-training samples. 
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Figure 2.6. Absolute levels of acetylcholine release. 
Absolute levels of ACh release in the ventral hippocampus 
accompanying inhibitory avoidance training in young and 
old rats. Baseline and training-associated increases in ACh 
release were significantly lower in old compared to young 
rats (Ps < 0.05 young vs. old). B=baseline samples; 
P=post-training samples. 
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CHAPTER 3: AGE-RELATED IMPAIRMENTS IN MEMORY AND IN CREB AND 
pCREB EXPRESSION IN HIPPOCAMPUS AND AMYGDALA FOLLOWING 
INHIBITORY AVOIDANCE TRAINING2 
This experiment examined whether age-related changes in CREB and pCREB 
contribute to the rapid forgetting seen in aged animals. Young (3-month-old) and aged 
(24-month-old) Fischer-344 rats received inhibitory avoidance training with a low (0.2 
mA, 0.4 s) or moderate (0.5 mA, 0.5 s) foot shock; memory was measured 7 days later. 
Other rats were euthanized 30 min after training, and CREB and pCREB expression 
levels were examined in the hippocampus, amygdala, and piriform cortex using 
immunohistochemistry. CREB levels decreased with age in the hippocampus and 
amygdala. After training with either shock level, young rats exhibited good memory and 
increases in pCREB levels in the hippocampus and amygdala. Aged rats exhibited good 
memory for the moderate but not the low shock but did not show increases in pCREB 
levels after either shock intensity. These results suggest that decreases in total CREB 
and in pCREB activation in the hippocampus and amygdala may contribute to rapid 
forgetting in aged rats. After moderate foot shock, the stable memory in old rats 
together with absence of CREB activation suggests either that CREB was 
phosphorylated in a spatiotemporal pattern other than analyzed here or that the 
stronger training conditions engaged alternate mechanisms that promote long-lasting 
memory. 
 
                                                             
2 This chapter appeared in its entirety in the journal Mechanisms of Ageing and Development and is referred to 
later in this dissertation as Morris and Gold, 2012a. Morris, K.A., and Gold, P.E. (2012a). Age-related impairments 
in memory and in CREB and pCREB expression in hippocampus and amygdala following inhibitory avoidance 
training. Mech. Ageing Dev., 133, 291-299. This article is reprinted with the permission of the publisher. 
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3.1. INTRODUCTION 
As seen in humans, rats and mice exhibit age-related impairments in learning 
and memory on many tasks. Often, the impairments are characterized in terms of rapid 
forgetting, in which aged rodents perform similarly to young adult rodents on memory 
tests soon after training, but have poor memory at later times as compared to young 
rodents (Barnes, 1991; Foster, 1999; Gold, 2001, 2005; Korol, 2002; Winocur, 1988). 
There are many examples of accelerated forgetting in aged rodents, with specific time 
courses that differ by task. In particular, memory for inhibitory avoidance training 
remains stable in young adult rats for weeks after training but decays within hours to 
days in old rats. Importantly, the age-related difference in forgetting rate is apparent 
despite similar or lower foot shock perceptual thresholds in old rats (Foster and Kumar, 
2007; Frye et al., 2010; Gold et al., 1982; Morris et al., 2010). Rapid forgetting is also 
evident in a variety of other tasks, including the water maze (Burke et al., 2008; Gage et 
al., 1984; Mabry et al., 1996; Rapp et al., 1987), reward reduction (Salinas and Gold, 
2005), social transmission of food preference (Countryman and Gold, 2007), visual 
discriminated avoidance (Gold et al., 1982), Barnes circular maze (Barnes and 
McNaughton, 1985), spatial reversal (Zornetzer et al., 1982), spontaneous alternation 
(Da Silva Costa-Aze et al., 2011; McNay and Gold, 2001; Stone et al., 1997), odor-
reward association (Roman et al., 1996), and eye-blink classical conditioning (e.g. 
Solomon et al., 1995; Woodruff-Pak et al., 2007). The breadth of examples of rapid 
forgetting suggests that this is a key characteristic of age-related changes in memory. 
Rapid forgetting seen during aging is analogous to similar findings seen after 
many treatments that interfere with cell and molecular processes associated with the 
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formation of new memories. Rapidly decaying memory is seen after administration of 
protein synthesis inhibitors, ERK/MAPK inhibitors, and inhibitors of transcription factors, 
such as cAMP response element binding protein (CREB), and is also seen in several 
knockout and transgenic mice with alterations aimed at these and other molecular 
targets (e.g. Alberini, 2009; Apergis-Schoute et al., 2005; Costa-Mattioli and Sonenberg, 
2008; Goelet et al., 1986; Guzowski et al., 2000; Houpt and Berlin, 1999; Izquierdo et 
al., 2006; Kandel, 2001; McGaugh, 2000; Taubenfeld et al., 2001; Trifilieff et al., 2006). 
The parallels between the rapid forgetting in these experiments and those seen in aged 
rodents suggest that similar cellular mechanisms may be involved. 
Of particular relevance to the experiments reported here, considerable evidence 
suggests that CREB is a transcription factor important to the formation of durable 
memories, perhaps converting rapidly decaying memories and short-term potentiation to 
more permanent forms (Benito and Barco, 2010; Carlezon et al., 2005; Colombo et al., 
2003; Josselyn, 2010; Silva et al., 1998; Taubenfeld et al., 1999; Yin and Tully, 1996). 
For example, interfering with CREB function via mutations or inhibitors generally 
disrupts memory assessed at long but not short times after training (Bourtchuladze et 
al., 1994; Brightwell et al., 2005, 2008; Frankland et al., 2004; Guzowski and McGaugh, 
1997; Josselyn et al., 2004; Yin et al., 1994), and these findings are analogous to the 
rapid forgetting seen in aged rodents. Several studies have examined CREB functions 
in aged rodents (cf. Lund et al., 2004). One consistent finding is that aged rodents are 
impaired in training-related activation of phosphorylated CREB (pCREB) in the 
hippocampus (Countryman and Gold, 2007; Kudo et al., 2005; Monti et al., 2005; Porte 
et al., 2008a; Xu et al., 2010). Several studies of chronically administered treatments 
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have identified substances that can attenuate age-related memory impairments while 
also enhancing CREB phosphorylation (Assunção et al., 2010; Li et al., 2009; Trofimiuk 
et al., 2010; Xu et al., 2010). Mouravlev et al. (2006) demonstrated that somatic gene 
transfer of CREB protein into the hippocampus of young adult rats prevented later 
formation of age-associated memory impairments. Also, Brightwell et al. (2004) found 
that aged rats with poor spatial memory have lower hippocampal CREB levels than do 
those with good spatial memory. However, prior aging studies have apparently not 
examined whether altering training conditions to promote stable memory formation in 
aged rodents would reverse deficits in CREB activation. 
The present report tested the hypothesis that age-related differences in the 
expression and activation of CREB and pCREB may contribute to the rapid forgetting 
that is characteristic of aged rodents. Therefore, we used an inhibitory avoidance task in 
which the rate of forgetting is accelerated in aged rats. In addition, increases in the 
aversive component of training result in better maintenance of memory, providing a 
comparison of conditions in which memory is rapidly or slowly forgotten. Thus, in the 
experiments reported here, rats were trained with either a low intensity foot shock, 
which led to age-related rapid forgetting, or a moderate intensity foot shock, which led to 
stable memory formation in both young and old rats. In past studies of aging and 
memory, CREB and pCREB expression were assessed only in the hippocampus. In the 
present experiments, CREB and pCREB expression levels were assessed with 
immunohistochemistry in brain sections collected 30 min after training from the 
amygdala and piriform cortex, as well as from hippocampal dentate gyrus, area CA3, 
and area CA1 (see Fig. 3.1).  
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3.2. MATERIALS AND METHODS 
3.2.1. Subjects 
 Young adult (3–4 mo.) and old (24–25 mo.) male Fischer-344 rats (Taconic 
Farms, Germantown, NY) were individually housed in translucent cages with a 12-h 
light/12-h dark cycle (lights on at 07:00 h) and ad libitum access to food and water. 
Animal pain and discomfort were minimized, and all experiments were conducted in 
accordance with animal care guidelines established by the National Institute of Health 
and the University of Illinois, which is fully accredited (AAALAC). 
 
3.2.2. Inhibitory Avoidance Training 
Rats were handled on 5 consecutive days for 5 min each day prior to behavioral 
training. All training and testing took place between 1200 and 1600 h. The inhibitory 
avoidance apparatus was a trough-shaped alleyway (91 cm long, 22.9 cm wide at the 
top, 7.6 cm wide at the bottom, and 15.2 cm deep) divided into lit (31 cm) and dark (60 
cm) compartments by a sliding door that could be lowered through the floor. Each rat 
was placed in the lit chamber facing the door. When the rat turned completely around, 
the door was lowered to a height approximately 2 cm above the floor. When the rat 
again turned toward the door, a timer was started to record the latency to enter the dark 
chamber. Upon entering the dark chamber, the rat received a brief foot shock (either 0.2 
mA, 0.4 s, or 0.5 mA, 0.5 s) and the door was closed to prevent re-entry into the lit 
chamber. The rat was then returned to the holding cage. For the initial behavioral 
characterization, retention latencies (max of 600 s) were tested 7 days after training 
using the same procedure. To measure CREB and pCREB levels, rats were euthanized 
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30 min after training and immunostaining procedures were used at a later time. Groups 
for the CREB and pCREB measures also included a cage control group, in which rats 
were left in their home cage until euthanasia, and a no shock group, in which rats were 
placed in the training apparatus and allowed to cross from the lit to dark compartment, 
but did not receive a foot shock. Ns = 4 for the initial behavioral characterization. For the 
immunohistochemistry studies, N = 7 for the young cage control group and Ns = 4 for all 
other groups. 
 
3.2.3. Perfusion and Brain Slicing 
Rats were deeply anesthetized with an overdose i.p. injection of sodium 
pentobarbital (Sigma–Aldrich, St. Louis, MO) and then perfused intracardially with 80 ml 
of 0.1 M phosphate-buffered saline followed by 80 ml of 4% paraformaldehyde in 0.1 M 
phosphate buffer. Rats were decapitated and the brains were removed and placed into 
4% paraformaldehyde in 0.1 M PB for ~72 h. The brains were transferred to 20% 
glycerol in 0.1 M PBS for ~48 h. Frozen sections (40 mM) were collected at -30 oC with 
a Leica 1800 cryostat (Leica Microsystems, Wetzlar, Germany). Slices through the 
dorsal hippocampus were collected and stored in a cryopreservative solution (250 mM 
40 KD polyvinylpyrrolidone, 880 mM sucrose, 30% v/v ethylene glycol, 50 mM sodium 
phosphate) at -20o C. 
 
3.2.4. Immunohistochemistry 
All steps took place at room temperature. All reactions were performed in 
duplicate, using alternating slices for CREB and pCREB staining. Slices were washed 
three times for 10 min each time in 0.05 M PBS initially and between all subsequent 
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steps. Slices were first incubated in blocking solution (1% H2O2, 1% NGS, 0.02% triton 
x-100, 0.05 M PBS) for 10 min. They were transferred to a preincubation solution (2% 
NGS, 0.4% triton x-100, 0.05 M PBS) for 20 min and then incubated overnight in a 
solution (1% NGS, 0.4% triton x-100, 0.05 M PBS) containing a rabbit primary antibody 
for CREB or Ser-133 phosphorylated CREB (Millipore, Billerica, MA) diluted 1:4000. 
The next day, the slices were placed for 1 h in a solution (1% NGS, 0.2% triton x-100, 
0.05 M PBS) containing a goat anti-rabbit biotinylated secondary antibody (Santa Cruz, 
Santa Cruz, CA). They were next incubated for 30 min with ABC reagent (Vector, 
Burlingame, CA) in 0.05 M PBS, followed by incubation with DAB substrate (Vector) for 
4 min. Slices were mounted onto slides and allowed to dry overnight. The next morning, 
slices were dehydrated with a graded ethanol series of washes, then coverslipped using 
DPX mountant (Sigma–Aldrich). 
 
3.2.5. Image Acquisition and Analysis 
 Sections were imaged using a Leica DM 6000B/CTR6000 light microscope and a 
Leica DFC350 FX video camera, which was interfaced to a PC computer. This system 
was used in conjunction with Image-Pro software (Media Cybernetics, Inc., Bethesda, 
MD) for image acquisition and for correction of unevenness in illumination across 
images. Image J software (NIH, Bethesda, MA) was used to quantify the optical density 
of CREB and pCREB staining in subregions of the hippocampus, amygdala, and 
piriform cortex. Fig. 3.1 shows the specific regions that were analyzed. A statistical 
thresholding method in Image J was used to ensure that only specifically labeled cells 
were being measured. For each image, the optical density of a nearby region with no or 
little specific staining was calculated and used for background subtraction. 
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3.2.6. Statistical Analyses 
 All analyses were performed using Statview software. The optical densities of 
CREB and pCREB immunostaining were analyzed using two-way ANOVAs with post 
hoc Fisher PLSD tests where appropriate. Behavioral results were analyzed using a 
non-parametric Kruskal-Wallis one-way analysis of variance, followed by Mann-Whitney 
tests for individual comparisons. 
 
3.3. RESULTS 
3.3.1. Behavioral Performance on the Inhibitory Avoidance Task. 
Fig. 3.2 shows training latencies (Left) and 7-day retention latencies (Right) of 
young and old rats trained on an inhibitory avoidance task. There were no significant 
age-related differences in training latencies. Young rats had maximum median retention 
latencies of 600 s following a 0.2 mA, 0.4 s or 0.5 mA, 0.5 s foot shock. The old rats had 
a maximum median retention latency following the moderate intensity foot shock, but a 
median retention latency of only 66.9 s with the lower intensity foot shock. Non-
parametric analysis of variance revealed a significant group effect (H = 8.7, p < .05). 
Post hoc analyses showed that old rats receiving the low intensity foot shock had 
significantly lower retention latencies compared to each of the other three groups (ps < 
.05). 
 
3.3.2. CREB and pCREB Immunostaining Following Training. 
Differences in immunostaining of pCREB, total CREB, as well as pCREB:CREB 
ratios, were examined in young and old rats 30 min after inhibitory avoidance training 
with a low (0.2 mA, 0.4 s) or moderate (0.5 mA, 0.5 s) foot shock. These groups were 
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compared to cage controls and to no shock controls, which were trained on inhibitory 
avoidance without the foot shock. These results are summarized in Table 3.1. 
 
3.3.2.1. Hippocampus: Dentate Gyrus 
Fig. 3.3 (A and B) shows pCREB immunostaining in the dentate gyrus region of 
the hippocampus. Activation of CREB by training was evident in young but not aged 
rats. A two-way ANOVA revealed a main effect of training on pCREB staining (F(3,27) = 
7.30, p < .01). In young rats, training with a 0.2 mA foot shock significantly enhanced 
pCREB staining compared to cage controls (p < .01). Training with a 0.5 mA foot shock 
enhanced pCREB staining compared to cage control, no shock, and 0.2 mA groups (ps 
< .03). In old rats, there were no significant increases in pCREB staining in response to 
training at either foot shock intensity. There was a main effect of age on pCREB (F(1,27) 
= 18.17, p < .001), indicating lower pCREB staining in old compared to young rats. Post 
hoc tests were used to identify age-related differences within training groups (e.g. young 
cage controls vs. old cage controls). There were significant age-related differences 
between the young and old rats in the 0.2 mA and 0.5 mA shock groups (ps < .05). In 
addition to the training and age effects, there was a significant age by training 
interaction (F(3,27) = 3.58, p < .05). 
There was an overall main effect of age (F(1,27) = 4.36, p < .05) on CREB 
immunostaining, with lower staining observed in old rats (Fig. 3.3C). There were no 
main effects of training on CREB staining (F(3,27) = 0.24). 
There was a main effect of training (F(3,27) = 4.76, p < .01) but not age (F(1,27) = 
1.38) on pCREB:CREB ratios (Fig. 3.3D). In young rats, training with a 0.2 mA shock 
increased pCREB:CREB ratios above those of cage control rats (p < .03). Training with 
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a 0.5 mA shock increased pCREB:CREB ratios compared to both cage control and no 
shock groups (ps < .03). In old rats, training did not significantly alter pCREB:CREB 
ratios, regardless of the foot shock intensity. 
 
3.3.2.2. Hippocampus: Area CA3 
There was a main effect of age (F(1,27) = 6.45, p < .03) but not training (F(3,27) = 
2.40) on pCREB immunostaining in area CA3 (Fig. 3.4A and B). However, post hoc 
analyses revealed no significant differences between groups. There was also a main 
effect of age (F(1,27) = 22.74, p < .0001) but not training (F(3,27) = 0.06) on CREB staining 
(Fig. 3.4C). Post hoc analyses revealed significantly lower CREB staining in old 
compared to young rats in the cage control, 0.2 mA shock, and 0.5 mA shock groups 
(ps < .05), but not in the no shock group. There was a main effect of age (F(1,27) = 4.87, 
p < .05) on pCREB:CREB ratios (Fig. 3.4D), suggesting higher ratios in old rats. There 
were no training effects on pCREB:CREB ratios (F(3,27) = 0.78). 
 
3.3.2.3. Hippocampus: Area CA1 
In area CA1, the effects on pCREB, CREB, and pCREB:CREB ratios were very 
similar to those seen in the dentate gyrus, and are therefore not presented in detail 
here. 
 
3.3.2.4. Basolateral Amygdala 
Both training (F(3,27) = 5.19, p < .01) and age (F(1,27) = 36.89, p < .0001) 
significantly affected pCREB immunostaining in the basolateral amygdala (Fig. 3.5A and 
B). In young rats, training with a 0.2 mA foot shock increased pCREB staining 
compared to cage controls (p < .05). Training with a 0.5 mA foot shock increased 
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pCREB staining compared to both cage and no shock controls (ps < .01). In old rats, 
training did not significantly alter pCREB staining, regardless of the shock intensity. 
Compared to cage controls, age-related deficits in pCREB activation were evident in the 
no shock, 0.2 mA shock, and 0.5 mA shock groups (ps < .05). There was also a 
significant age by training interaction (F(3,27) = 3.29, p < .05). 
 There was a main effect of age (F(1,27) = 21.39, p < .0001) but not training (F(3,27) 
= 0.20) on CREB immunostaining (Fig. 3.5C). Post hoc analyses revealed significantly 
lower CREB staining in old rats in the cage control and 0.5 mA shock groups (ps < .05). 
There was a main effect of training (F(3,27) = 3.39, p < .05) but not age (F(1,27) = 
2.36) on pCREB:CREB ratios (Fig. 3.5D). In young rats, the 0.2 mA shock group had 
significantly higher ratios compared to cage control rats (p < .05). The 0.5 mA shock 
group had significantly higher ratios compared to both the cage control and no shock 
groups (ps < .05). In old rats, training did not have a significant effect on pCREB:CREB 
ratios. 
 
3.3.2.5. Lateral Amygdala 
In the lateral amygdala, the effects on pCREB, CREB, and pCREB:CREB ratios 
were similar those seen in the basolateral amygdala, with the major exception being 
lack of a training effect on pCREB:CREB ratios in the lateral amygdala (see Table 3.1). 
Therefore, these results are not presented in detail here. 
 
3.3.2.6. Piriform cortex 
There were no main effects of age (Fs(1,27) < 3.67) or training (Fs(3,27) < 0.07) on 
pCREB, CREB, or pCREB:CREB ratios in the piriform cortex (Fig. 3.6). 
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3.4. DISCUSSION 
3.4.1. Age-related Differences in Memory 
Training with a low intensity foot shock produced stable 7-day memory in young 
rats, but led to poor 7-day memory in old rats. These results support prior work 
demonstrating rapid age-related forgetting following inhibitory avoidance training (Gold 
et al., 1982; Morris et al., 2010). In particular, Gold et al. (1982) trained rats with a low 
intensity foot shock and training-testing intervals ranging from 2 h to 6 weeks. Young 
rats had stable memory for at least 3 weeks after training. Old rats had comparable or 
even better memory than young rats 2 h after training. However, the old rats exhibited 
slight deficits after 1 day, and were significantly impaired after 7 days. Thus, old rats 
exhibited rapid forgetting for inhibitory avoidance, with memory intact for hours after 
training, but with memory impairments emerging during the days after training. 
Importantly, this operational definition of forgetting may reflect memories with variable 
time courses depending on the salience of the initiating events.  
In contrast to the results with the low foot shock, training with a moderate 
intensity foot shock resulted in stable 7-day memory in both young and old rats. These 
results are similar to findings by Gold et al. (1982), and indicate that forgetting rates in 
old rats can be slowed by increasing the saliency of the training foot shock, perhaps 
with concomitant increases in neural modulators of memory associated with the higher 
training-related arousal levels. Together, the behavioral results presented here provide 
a good model with which to examine changes in CREB expression and activation that 
might contribute to rapid forgetting in aged rats. 
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3.4.2. Age-Related Differences in CREB and pCREB Expression at Baseline 
At baseline, CREB levels were lower in aged vs. young adult rats in area CA3 
and in the basolateral and lateral amygdala. Comparable changes were not evident in 
the dentate gyrus, area CA1, or piriform cortex, although the latter brain region had high 
CREB expression levels as seen previously (Ferrer et al., 1996; Herdegen et al., 1993). 
The age-related reductions in hippocampal CREB observed here are consistent with 
past findings revealing decreased expression of hippocampal CREB in old Fischer-344 
rats (Countryman and Gold, 2007). Other studies have shown age-related reductions in 
CREB levels in whole hippocampal homogenates from Long Evans (Brightwell et al., 
2004) and Wistar rats (Trofimiuk et al., 2010). The age-related decreases in CREB 
expression in the amygdala have not, to our knowledge, been noted before. The 
decreased expression of CREB in the hippocampus and amygdala with age, as well as 
the decreased training-related activation of CREB described below, may contribute to 
age-related memory impairments. The memory impairments are analogous to those 
seen in CREB knockout mice and in rats and mice treated with CREB antisense 
oligonucleotides, RNA interference, or dominant negative mutations, any of which 
impairs the formation of long-lasting memory and reduces the durability of long-term 
potentiation (Bourtchuladze et al., 1994; Canal et al., 2008; Florian et al., 2006; 
Guzowski and McGaugh, 1997; Josselyn, 2010; Peters et al., 2009; Pittenger et al., 
2002; Won and Silva, 2008). 
 Importantly, age-related changes in CREB, as well as changes in expression of 
pCREB described below, do not likely reflect differences in cell numbers or cell 
morphology between young and old rats. Studies utilizing stereological methods for 
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quantification have found that neuron numbers are preserved in the hippocampus of old 
rats (Gallagher et al., 2003; Rapp and Gallagher, 1996; Rasmussen et al., 1996). 
Likewise, another study reported no significant volume or cell loss in the hippocampus 
or amygdala of aged mice (Von Bohlen und Halbach and Unsicker, 2002). 
 The age-related decreases in CREB levels in several brain regions suggest that 
some estimates of age-related changes in behaviorally elicited increases in pCREB 
levels may reflect the loss of CREB per se. Several recent studies of changes during 
aging in pCREB levels in the hippocampus have measured only pCREB or have used 
total CREB levels to normalize for changes in pCREB (e.g. Assunção et al., 2010; 
Hattiangady et al., 2005; Li et al., 2009; Trofimiuk et al., 2010; Xing et al., 2010; Xu et 
al., 2010; Zhao et al., 2009). The present results suggest that quantifying total CREB 
levels is important to interpret correctly age- or activity-dependent changes in pCREB in 
old rats. Further, using CREB levels for normalization in aging studies may make it 
difficult to compare directly results across age groups, since total CREB levels may 
decline with age in a brain area-specific manner. 
 
3.4.3. Age-Related Differences in pCREB Expression in Response to Training 
CREB phosphorylation in the piriform cortex has been shown to be responsive to 
several stimuli (Alvarez-López et al., 2004; Dere et al., 2008; Estrada and Isokawa, 
2009; Kim et al., 2006; Pandey et al., 2001a,b; Wang et al., 2007). However, this is the 
first study, to our knowledge, to examine CREB activation in the piriform cortex after 
inhibitory avoidance training, revealing no evidence for pCREB increases after training 
in either young or aged rats. The results contrast with those showing c-Fos expression 
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and ERK activation in piriform cortex induced by active avoidance training in young 
adult rats (Radwanska et al., 2010). 
A striking result was that there were substantial age-related differences in 
activation of CREB in response to training in the hippocampus and amygdala. In young 
adult rats, pCREB expression in the dentate gyrus, area CA1, and the lateral and 
basolateral amygdala increased 30 min after training with a low foot shock as compared 
to expression levels in young cage controls. Training with a moderate intensity foot 
shock further enhanced pCREB levels in the same brain regions. In parallel groups of 
young rats, both shock intensities produced high avoidance latencies in memory tests 7 
days after training. These results are consistent with the view that, in young adult rats, 
CREB activation may be an important component or marker of long-term memory 
processes occurring after training. The results obtained in hippocampal regions agree 
with a number of other studies showing increased hippocampal CREB phosphorylation 
following inhibitory avoidance training in young adult rats, which can be abolished by 
treatments that interfere with memory processes (Cammarota et al., 2000; Taubenfeld 
et al., 1999, 2001; Viola et al., 2000). The amygdala results also agree with several 
studies demonstrating enhanced CREB phosphorylation in the basolateral and/or lateral 
amygdala following fearful or stressful stimuli (Bilang-Bleuel et al., 2002; Hubbard et al., 
2007; Ilin and Richter-Levin, 2009; Kogan and Richter-Levin, 2008; Lin et al., 2003; 
Saha and Datta, 2005; Shen et al., 2004; Stanciu et al., 2001). 
 In marked contrast to the results obtained with young adult rats, aged rats did not 
show significant increases in pCREB expression in any brain region after training with 
either the low or moderate shock intensity. In old rats, pCREB levels in the dentate 
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gyrus, area CA1, and lateral and basolateral amygdala, i.e. those areas responsive to 
training in young rats, were similar to those of aged cage controls and were generally 
significantly lower than those in corresponding groups and samples of young rats. 
Viewed across all brain areas, age-related decreases in total CREB cannot entirely 
account for these impairments in CREB phosphorylation, since basal CREB levels in 
area CA1 and the dentate gyrus were similar between young and old rats. Rather, the 
findings suggest that age-related impairments upstream to CREB activation may be an 
important contributor to age-related impairments in memory. This interpretation is 
consistent with recent evidence that overexpression of CREB in the hippocampus 
improves memory in young but not middle-aged rats (East et al., 2011), perhaps due to 
an inability of middle aged rats to engage upstream activators of CREB phosphorylation 
when needed. 
The present results are the first to identify substantial age-related impairments in 
CREB activation in the amygdala and hippocampus after inhibitory avoidance training. 
The failure to activate CREB in the amygdala may have significant consequences to 
modulation of memory in other neural systems, such as the hippocampus, and may 
contribute to the decreased pCREB after training in the hippocampus. Consistent with 
this possibility, intra-amygdala injections of beta-adrenergic agonists and antagonists, 
drugs that enhance and impair memory respectively, increase and decrease expression 
of activity-regulated cytoskeletal protein (Arc) in the hippocampus in conjunction with 
modulation of memory (McIntyre et al., 2005). These findings suggest that age-related 
deficiencies in amygdala modulation of hippocampal functions may be important in 
mediating the rapid forgetting and rapid decay of neural plasticity seen in aged rodents. 
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The present results also agree with a number of studies showing age-related 
impairments in CREB activation in a variety of hippocampal-dependent tasks 
(Countryman and Gold, 2007; Kudo et al., 2005; Monti et al., 2005; Porte et al., 2008a; 
Xu et al., 2010). Recent studies also indicate that long-term administration of certain 
compounds, including procyandins (Xu et al., 2010), green tea (Assunção et al., 2010; 
Li et al., 2009), and St. John’s wort (Trofimiuk et al., 2010), can reverse age-related 
deficits in CREB activation in concert with memory enhancement. Thus, these findings 
are consistent with the view that a failure to activate CREB after training contributes to 
age-related memory impairments. 
 The present experiments included a condition, moderate intensity foot shock 
used during training, which tested further the importance of CREB activation for long-
lasting memory. On the basis of past findings (Gold et al., 1982), we expected the 
moderate shock condition to result in longer maintenance of memory for inhibitory 
avoidance training, a result confirmed here. We further expected that the moderate 
training shock would also result in greater CREB activation that would parallel the better 
memory scores. This result was clearly not evident: Raising the foot shock intensity 
reversed age-related impairments in 7-day memory but did not increase CREB 
phosphorylation in the hippocampus or amygdala of old rats, as it did in young rats. 
Thus, CREB activation was dissociated from memory formation in old rats trained with 
the moderate foot shock intensity.  
 There are several possible explanations for the apparent dissociation between 
CREB activation and memory formation. In the present experiment, measurements of 
CREB activation were limited to a single time point, 30 min after training. Although some 
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studies suggest there is rapid and long-lasting CREB activation following training (e.g. 
Taubenfeld et al., 2001, 1999), others have observed specific and even delayed time 
windows of CREB phosphorylation after training (Bernabeu et al., 1997; O’Connell et 
al., 2000). Therefore, an earlier or later time point might reveal training-related 
increases in pCREB levels that would be associated with the stable memory observed 
here after training with the moderate shock intensity. It is also possible that the 
quantitative histochemistry methods used here were not sufficiently sensitive to reveal 
increases after the moderate shock intensity. Given the greater increase in pCREB 
expression levels seen in young rats after the moderate shock intensity, this seems 
unlikely, though the possibility cannot be fully discounted. Although pCREB activation in 
young rats appeared more or less uniform across large numbers of cells, such 
widespread activation may not be necessary for memory formation. For instance, Han 
et al. (2007, 2009) found that altering CREB function in small numbers of sparsely 
distributed cells in the lateral amygdala can affect formation of auditory fear memory 
(Han et al., 2007, 2009; Zhou et al., 2009). Sparse distribution of critical neurons 
expressing CREB activation would likely be missed using the immunohistochemistry 
methods employed here. Utilization of a cell counting strategy or of more quantitative 
techniques, such as ELISAs or western blots, may be helpful in providing corroborative 
molecular evidence of the optical density measurements presented here. 
Another possibility is that the dissociation between CREB and memory may 
indicate that CREB activation is not required for memory formation in old rats. This view 
is consistent with a number of studies showing stable formation of memory and long-
term potentiation in CREB knockout and mutant mice (Balschun et al., 2003; Gass et 
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al., 1998; Rammes et al., 2000). Although several studies do indicate deficits in long-
term memory in CREB mutant mice (Bourtchuladze et al., 1994; Sekeres et al., 2010), 
these deficits can often be reversed by altering training procedures or by administering 
memory-enhancing agents (Frankland et al., 2004; Kogan et al., 1997; Canal et al., 
2008). Further, the idea that CREB activation is not necessary for the formation of 
stable memories after the moderate shock is consistent with the possibility that the 
moderate shock level recruits additional molecular components of memory formation 
compared to those seen with the lower shock. In young rats, the behavioral measure of 
memory is maximal at both shock intensities, thereby obscuring the utility of additional 
molecular mechanisms. However, in aged rats, the stable memory after training with the 
moderate shock, coupled to the absence of CREB activation, may reflect the 
importance of these additional molecular mechanisms. In this regard, the study of stable 
memory in aged rats may be a condition favorable to investigation of these additional 
factors. 
 
3.5. FIGURES 
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Figure 3.1. Illustration of the areas targeted in this study. 
The targeted areas were the dentate gyrus (DG), CA3, and CA1 of the hippocampus, the lateral 
(LA) and basolateral (BLA) nuclei of the amygdala, and the piriform cortex. Photomicrographs 
show representative CREB immunoreactivity in each region. Scale bar = 200 mm. Adapted with 
permission from Paxinos and Watson (2005). 
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Figure 3.2. Training and 7-day retention latencies in young and old rats trained on inhibitory 
avoidance with a 0.2 or 0.5 mA foot shock. 
(Left) There were no significant differences in training latencies across groups. (Right) Old rats 
had significantly lower 7-day retention latencies following the low intensity foot shock than did all 
other groups (*) ps < .05. Note that old rats exhibited maximal retention latencies after training 
with the higher foot shock intensity. 
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Figure 3.3. Age- and training-associated differences in pCREB and CREB immunoreactivity in 
the dentate gyrus of the hippocampus. 
(A) Representative photomicrographs of pCREB immunostaining. Scale bar = 50 mm. (B) 
Young rats had significantly enhanced pCREB levels following training with a low or moderate 
intensity foot shock, whereas old rats had training-related deficits in pCREB activation. (*) p < 
.01 vs. young cage controls. (**) ps < .05 vs. young cage control, no shock, and 0.2 mA. (C) 
Total CREB levels were similar between young and old rats and not altered by training. (D) 
Young rats had significantly higher ratios of pCREB:CREB after training with a low or moderate 
intensity foot shock, whereas old rats had training-related deficits in pCREB:CREB ratios. (*) p < 
.05 vs. young cage controls. (**) ps < .05 vs. young cage controls and young no shock. 
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Figure 3.4. Age- and training-associated differences in pCREB and CREB immunoreactivity in 
area CA3 of the hippocampus. 
(A) Representative photomicrographs of pCREB immunostaining. Scale bar = 50 mm. (B) 
pCREB levels were similar between young and old rats and not significantly altered by training. 
(C) There were significantly lower CREB levels in old compared to young rats. (D) There were 
no significant age- or training-related differences in pCREB:CREB ratios. 
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Figure 3.5. Age- and training-associated differences in pCREB and CREB immunoreactivity in 
the basolateral amygdala. 
(A) Representative photomicrographs of pCREB immunostaining. Scale bar = 50 mm. (B) 
Young rats had significantly enhanced pCREB levels following training with a low or moderate 
intensity foot shock, whereas old rats had training-related deficits in pCREB activation. (*) p < 
.05 vs. young cage controls. (**) ps < .01 vs. young cage controls and no shock. (C) Total 
CREB levels were significantly lower in old compared to young rats. (D) Young rats had 
significantly higher ratios of pCREB:CREB after training with a low or moderate intensity foot 
shock, whereas old rats had training-related deficits in pCREB:CREB ratios. (*) p < .05 vs. 
young cage controls. (**) ps < .05 vs. young cage controls and no shock. 
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Figure 3.6. Age- and training-associated differences in pCREB and CREB immunoreactivity in 
the piriform cortex. 
(A) Representative photomicrographs of pCREB immunostaining. Scale bar = 50 mm. There 
were no age- or training-related differences in pCREB (B), CREB (C), or ratio of pCREB:CREB 
(D). 
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Table 3.1. Summary of Immunohistochemistry Results. 
 
 
 TRAINING EFFECT AGE EFFECT 
 YOUNG RATS OLD RATS  
pCREB    
DG ✓  ✓ 
CA1 ✓  ✓ 
CA3    
BLA ✓  ✓ 
LA ✓  ✓ 
PIR    
CREB    
DG    
CA1    
CA3   ✓ 
BLA   ✓ 
LA   ✓ 
PIR    
pCREB:CREB    
DG ✓   
CA1 ✓   
CA3    
BLA ✓   
LA    
PIR    
 
✓denotes significant main effect of age or training with foot shock, along with significant effect 
in at least one post hoc planned comparison; Brain regions analyzed were dentate gyrus (DG), 
area CA1, and area CA3 of the hippocampus, basolateral (BLA) and lateral (LA) amygdala, and 
piriform cortex (PIR). 
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CHAPTER 4: EPINEPHRINE AND GLUCOSE MODULATE TRAINING-RELATED 
CREB PHOSPHORYLATION IN OLD RATS: RELATIONSHIPS TO AGE-RELATED 
MEMORY IMPAIRMENTS 
Epinephrine enhances memory in young adult rats, in part, by increasing blood 
glucose levels needed to modulate memory. In old rats, epinephrine is deficient at 
raising blood glucose levels and thus is only moderately effective at enhancing memory. 
The diminished function of this neuroendocrine response in old rats may alter 
downstream neurochemical and molecular mechanisms needed to upregulate memory 
processes. In the first experiment reported here, young adult and old rats were trained 
on an inhibitory avoidance task with immediate post-training injections of aCSF or 
glucose into the dorsal hippocampus. Old rats had significant memory impairments 
compared to young rats 7 days after training. Intrahippocampal injections of glucose 
reversed age-related deficits, improving memory scores in old rats to values seen in 
young rats. The second experiment examined age-related changes in training-related 
activation of the transcription factor CREB, which is widely implicated in memory 
formation and may act downstream of hormonal and metabolic signals. Young adult and 
old rats were trained on inhibitory avoidance with immediate post-training injections of 
saline, epinephrine, or glucose. After training, old rats had significant impairments in 
CREB phosphorylation in area CA1 and the dentate gyrus region of the hippocampus, 
and in the basolateral and lateral amygdala. Epinephrine and glucose attenuated age-
related deficits in CREB phosphorylation, but were more effective in the amygdala and 
hippocampus, respectively. Together, these results support the view that age-related 
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changes in blood glucose responses to epinephrine contribute to memory impairments, 
which may be related to alterations in regional patterns of CREB phosphorylation. 
 
4.1. INTRODUCTION 
 Memory impairments accompany healthy aging in a variety of species. The 
impairments often take the form of rapid forgetting of recently learned information in 
both humans (Gagnon and Belleville, 2011; Huppert and Kopelman, 1989; Munro 
Cullum et al., 1990; Park et al., 1988) and rodents (Barnes, 1991; Countryman and 
Gold, 2007; Foster, 1999; Gold, 2005, 2008; Gold et al., 1982; Korol, 2002; Quartermain 
et al., 1988; Salinas and Gold, 2005; Winocur, 1988; Zornetzer et al., 1982). Previous 
work in rodents suggests that rapid forgetting may reflect deficits in neurobiological 
mechanisms of memory formation initiated during or soon after training. For example, 
old rodents have training-related alterations in neurotransmitter release, calcium 
signaling, and gene expression within the brain, all of which may be interrelated and 
contribute to memory impairments (Burke and Barnes, 2006; Dickstein et al., 2007; 
Kelly et al., 2006; Mora et al., 2007; Toescu and Verkhratsky, 2007; Welsh and Gold, 
1984; Yankner et al., 2008).  
Changes outside of the brain may also make important contributions to age-
related impairments in memory processes. Substantial evidence suggests that 
alterations in peripheral hormones and neuroendocrine systems during aging can alter 
central neurobiological processes, producing deficits in memory and synaptic plasticity 
(Conrad and Bimonte-Nelson, 2010; Foy, 2011; Frick, 2009; Janowsky, 2006; Korol and 
Gold, 2007; Lupien et al., 2009). In particular, numerous studies indicate that deficits in 
rising blood glucose levels after peripheral epinephrine release contribute to age-related 
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impairments in memory processes (Gold, 2005; Gold and Korol, 2010; Korol, 2002; 
Korol and Gold, 1998, 2007; Mabry et al., 1996; Messier, 2004). Epinephrine is a 
hormone released from the adrenal medulla as a response to arousal. In young adult 
rats, endogenous release of epinephrine facilitates stable memory formation for 
temporally associated events. Likewise, peripheral injections of epinephrine can convert 
short-lasting memories and the early phase of long-term potentiation (LTP) to more 
lasting forms (Korol and Gold, 2008). Since peripheral epinephrine cannot readily enter 
the brain from blood, epinephrine mediates its effects on memory largely by liberating 
glucose from liver glycogen stores, thus increasing the supply of glucose to the brain 
during cognitively demanding times (Gold, 2005, 2008; Gold and Korol, 2010; Korol and 
Gold, 2007). The additional provision of glucose to the brain provides energy to support 
memory processes, possibly by contributing to lactate production in astrocytes with 
provision to neurons during cognitive processing (Newman et al., 2011; Suzuki et al., 
2011).  
Several studies show that epinephrine is deficient at raising blood glucose levels 
in old rats. Though old rats exhibit higher circulating epinephrine levels following training 
or exposure to a novel environment, they do not show the parallel increases in blood 
glucose levels seen in young rats (Mabry et al., 1995a,b,c). Likewise, peripheral 
injections of epinephrine fail to increase blood glucose levels in old rats to the levels 
seen in young rats (Morris et al., 2010). These age-related deficits in blood glucose 
responses to epinephrine can affect downstream neurochemical and behavioral 
memory processes. One mechanism by which glucose may enhance memory is by 
increasing behaviorally-elicited release of the neurotransmitter acetylcholine (Gold, 
 79 
2003; Kopf et al., 2001; Ragozzino and Gold, 1995; Ragozzino et al., 1996, 1998). In 
young adult rats, post-training injections of epinephrine or glucose enhance 
hippocampal acetylcholine release similarly while improving later memory for an 
inhibitory avoidance task. In contrast, glucose is more effective than epinephrine at 
enhancing acetylcholine release and improving memory in old rats (Morris et al., 2010). 
These results suggest that glucose administration in old rats may bypass the need for 
epinephrine to increase blood glucose levels and activate the downstream release of 
acetylcholine.  
Age-related impairments in blood glucose responses to epinephrine may also 
affect downstream molecular processes, particularly those activated by cholinergic 
signaling. Several studies suggest that acetylcholine modulates phosphorylation of 
cAMP response element-binding protein (CREB) in the brain, most likely through 
activation of nicotinic acetylcholine receptors (Chang and Berg, 2001; Dajas-Bailador 
and Wonnacott, 2004; Hu et al., 2002). CREB is a transcription factor widely implicated 
in activity-dependent neuronal plasticity and the formation of durable memories 
(Alberini, 2009; Benito and Barco, 2010; Carlezon et al., 2005; Colombo et al., 2003; 
Silva et al., 1998; Taubenfeld et al., 1999; Yin and Tully, 1996). In young adult rats, 
interfering with CREB function via mutations or inhibitors generally disrupts long-term 
memory while leaving short-term processes intact (Bourtchuladze et al., 1994; 
Brightwell et al., 2005, 2008; Guzowski and McGaugh, 1997; Josselyn et al., 2004), 
mimicking age-related rapid forgetting. In old rats, there are significant age-related 
deficits in CREB activation after training in a variety of behavioral tasks, and these 
deficits correlate with memory impairments and rapid forgetting (Countryman and Gold, 
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2007; Kudo et al., 2005; Monti et al., 2005; Porte et al., 2008a; Xu et al., 2010). Several 
recent studies have shown that long-term exercise programs or chronic administration 
of various exogenous compounds can attenuate age-related impairments in CREB 
activation while improving performance in behavioral tasks (Aguiar et al., 2011; 
Assunção et al., 2010; Li et al., 2009; Trofimiuk et al., 2010; Xu et al., 2010). However, it 
is difficult to tell if these effects are specific to memory processes, given that the 
treatments were administered for several weeks or months prior to training. Few studies 
have examined how post-training administration of endogenous memory enhancing 
agents, such as epinephrine and glucose, may modulate memory and CREB function in 
old rats. 
Of particular relevance to the current experiments, a recent study found that old 
rats are significantly impaired in CREB phosphorylation following inhibitory avoidance 
training, even when the foot shock intensity is raised to promote stable memory 
formation (Morris and Gold, 2012a). Similarly, other work has shown that old rats do not 
exhibit a foot shock-related rise in blood glucose levels, even with relatively high foot 
shock intensities (Mabry et al., 1995c). Together, these results suggest that old rats are 
significantly impaired in their ability to initiate CREB-mediated transcriptional processes, 
which may reflect deficits in blood glucose rises and associated impairments in 
acetylcholine release soon after training.  
The present experiments utilized post-training designs to examine how deficits in 
blood glucose responses to epinephrine in old rats may contribute to impairments in 
memory and CREB activation. The first experiment tested the hypothesis that direct 
brain injections of glucose after inhibitory avoidance training could reverse age-related 
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memory impairments. The second experiment examined the hypothesis that glucose 
would be more effective than epinephrine at modulating downstream CREB 
phosphorylation in the brain, similar to glucose’s greater efficacy in previously tested 
neurochemical and behavioral measures. 
 
4.2. METHODS 
4.2.1. Subjects 
Young adult (3 to 4 mo.) and old (24 to 25 mo.) male Fischer-344 rats (Taconic 
Farms, Germantown, NY) were individually housed in translucent cages with a 12-h 
light/dark cycle (lights on at 07:00 h) and ad libitum access to food and water. Animal 
pain and discomfort were minimized. All experiments were conducted at the University 
of Illinois, which is fully accredited (AAALAC), in accordance with animal care guidelines 
established by the National Institute of Health. 
 
4.2.2. Surgery 
Rats were anesthetized with isoflurane and placed in a stereotaxic apparatus. 
Stainless steel guide cannulae (Plastics One, Roanoke, VA) were implanted bilaterally 
into the dorsal hippocampus of young [coordinates: - 3.2 mm from bregma; ± 3 mm 
lateral; - 1.9 mm deep from dura] and old rats [coordinates: - 3.4 mm from bregma; ± 
3.1 mm lateral; - 2.1 mm deep from dura], according to the atlas of Paxinos and Watson 
(2005). Rats were monitored and allowed to recover for 7 days after surgery before 
further experimentation.  
 
4.2.3. Inhibitory Avoidance Training 
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Rats were handled for 3-4 min each day on 5 consecutive days prior to inhibitory 
avoidance training. All training took place between 12:00 and 16:00 h. The inhibitory 
avoidance apparatus was a trough-shaped alleyway (91 cm long, 22.9 cm wide at the 
top, 7.6 cm wide at the bottom, and 15.2 cm deep) divided into lit (31 cm) and dark (60 
cm) compartments by a sliding door that could be lowered through the floor. Each rat 
was placed in the lit chamber facing the door. When the rat turned completely around, 
the door was lowered to a height approximately 2 cm above the floor. When the rat 
again turned toward the door, a timer was started to record the training latency, defined 
as the time taken to enter (cross all four limbs into) the dark chamber. Rats that failed to 
enter the dark chamber within two minutes were not included in the study. Upon 
entering the dark chamber, the rat received a single foot shock (0.2 mA, 0.4 sec) and 
the door was closed to prevent reentry into the lit chamber. These training conditions 
were similar to those with which we have seen rapid forgetting in senescent rats and 
stable memory in young adult rats in past experiments (Gold et al., 1982; Morris et al., 
2010; Morris et al., 2012; Sternberg et al., 1985). In these past experiments, memory in 
aged rats was not impaired during the first hours after training but forgetting emerged 
within 1-7 days after training in aged rats, at times when young rats do not exhibit 
forgetting for the inhibitory avoidance experiences. Also, past tests revealed that aged 
Fischer-344 rats do not have higher foot shock thresholds than do young adult rats 
(Gold et al., 1982). Thus, the conditions used in the present experiment were 
appropriate for tests of the neurobiological concomitants of rapid forgetting in aged rats. 
For the microinfusion experiments, rats received immediate post-training 
infusions of artificial cerebral spinal fluid (aCSF) or glucose and were then returned to 
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the holding cage. Memory was assessed by measuring latencies (max of 600 sec) on a 
test trial 7 days later using the same procedure as above, but without the foot shock. 
For the immunohistochemistry experiments, rats received an immediate post-training 
subcutaneous injection of saline (0.9%), glucose (250 mg/kg), or epinephrine (0.1 
mg/kg) and were then returned to the holding cage. To measure CREB and 
phosphorylated CREB (pCREB) levels, rats were euthanized 30 min after training and 
immunostaining procedures were used at a later time. There are differences across 
studies in the optimal time to assess maximal pCREB responses to training. The 30-min 
time point was chosen based on prior work showing robust increases in CREB 
phosphorylation in young adult rats at that time under similar training conditions (Morris 
and Gold, 2012a). We also hypothesized that 30 min would allow sufficient time for 
post-training treatments to enhance cell signaling processes related to CREB 
phosphorylation. 
 
4.2.4. Microinfusions 
Immediately following training, microinfusion probes (Plastics One) were inserted 
through the guide cannulae to a point 1 mm below the guide cannulae tips. A solution of 
aCSF (128 mM NaCl, 2.5 mM KCl, 1.3 mM CaCl2, 2.1 mM MgCl2, 0.9 mM NaH2PO4, 
2.0 mM Na2HPO4, pH 7.4) containing either 1.0 or 33.4 mM glucose was infused 
bilaterally into the dorsal hippocampus at a rate of 0.25 µl / min for 2 min. The 1.0 mM 
glucose concentration in control aCSF is based on evidence that this level is seen at 
baseline in hippocampal CSF (McNay and Gold, 1999). Infusion probes were left in 
place for an additional 1 min to allow solutions to diffuse away from the probe tips. In 
contrast to glucose, epinephrine does not cross readily from blood to brain and neither 
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circulating nor central epinephrine appears to act at adrenergic receptors in the 
hippocampus. Therefore, intrahippocampal injections of epinephrine were not tested 
here. 
 
4.2.5. Perfusion and Brain Slicing 
Rats were deeply anesthetized with an overdose i.p. injection of sodium 
pentobarbital (Sigma-Aldrich, St. Louis, MO) and then perfused intracardially with 80 ml 
of 0.1 M phosphate-buffered saline (PBS) followed by 80 ml of 4% paraformaldehyde in 
0.1 M phosphate buffer. Rats were decapitated and the brains were removed and 
placed into 4% paraformaldehyde in 0.1 M PB for ~72 hrs. The brains were transferred 
to 20% glycerol in 0.1 M PBS for ~48 hrs. Frozen sections (40 µM) were collected at -
30o C with a Leica 1800 cryostat (Leica Microsystems, Wetzlar, Germany). For the 
immunohistochemistry experiments, slices through the dorsal hippocampus were 
collected and stored in a cryopreservative solution (250 mM 40 KD polyvinylpyrrolidone, 
880 mM sucrose, 30% v/v ethylene glycol, 50 mM sodium phosphate) at -20o C. For the 
microinfusion experiments, sections containing the guide cannulae tracts were mounted 
on slides, dried, stained with cresyl violet, and visualized under a light microscope. 
Behavioral data were discarded for those rats with probe sites outside of the dorsal 
hippocampus. 
 
4.2.6. Immunohistochemistry 
All steps took place at room temperature. All reactions were performed in 
duplicate, using alternating slices for pCREB and CREB staining ~3.3 mm posterior to 
bregma. Slices were washed three times for 10 min each time in 0.05 M PBS initially 
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and in between all subsequent steps. Slices were first incubated in blocking solution 
(1% H2O2, 1% normal goat serum (NGS), 0.02% triton x-100, 0.05 M PBS) for 10 min. 
They were transferred to a pre-incubation solution (2% NGS, 0.4% triton x-100, 0.05 M 
PBS) for 20 min and then incubated overnight in a solution (1% NGS, 0.4% triton x-100, 
0.05 M PBS) containing a rabbit primary antibody for Ser-133 phosphorylated CREB or 
total CREB (Millipore, Billerica, MA) diluted 1:4000. The next day, the slices were 
placed for 1 hr in a solution (1% NGS, 0.2% triton x-100, 0.05 M PBS) containing a goat 
anti-rabbit biotinylated secondary antibody (Santa Cruz, Santa Cruz, CA). They were 
next incubated for 30 min with ABC reagent (Vector, Burlingame, CA) in 0.05 M PBS, 
followed by incubation with DAB substrate (Vector) for 4 min. Slices were mounted onto 
slides and allowed to dry overnight. The next morning, slices were dehydrated with a 
graded ethanol series of washes, then coverslipped using DPX mountant (Sigma-
Aldrich). 
 
4.2.7. Image Acquisition and Analysis 
Sections were imaged using a Leica DM 6000B/CTR6000 light microscope and a 
Leica DFC350 FX video camera, which was interfaced to a PC computer. This system 
was used in conjunction with Image-Pro software (Media Cybernetics, Inc., Bethesda, 
MD) for image acquisition and to correct for unevenness in illumination across images. 
Image J software (NIH, Bethesda, MA) was used to quantify the optical density of 
pCREB and CREB staining. The six brain regions analyzed were the dentate gyrus and 
areas CA3 and CA1 of the hippocampus, the basolateral and lateral nuclei of the 
amygdala, and the piriform cortex. The hippocampus and amygdala regions were 
selected because of prior evidence that training, as in the present experiment, elicited 
 86 
clear phosphorylation of CREB in young rats but not in old rats. The piriform cortex was 
selected as a control region based on evidence that CREB phosphorylation is not 
altered by age or by training in either young or old rats (Morris and Gold, 2012a). Morris 
and Gold (2012a) provides an illustration of the specific targeted areas as well as a 
detailed discussion of CREB activation in these brain regions. The auto-thresholding 
method in Image J was used to ensure that only specifically labeled cells were being 
measured. For each image, the optical density of a nearby region with no or little 
specific staining was calculated and used for background subtraction.  
 
4.2.8. Statistical Analyses 
All analyses were performed using Statview software. Behavioral training and 
retention latencies were analyzed using a non-parametric Kruskal-Wallis one-way 
analysis of variance, followed by Mann-Whitney tests for individual comparisons, if 
appropriate. The immunohistochemistry experiments were run in two cohorts. In the first 
cohort, rats were trained on the inhibitory avoidance task with a post-training injection of 
saline or glucose. These groups were compared to untrained rats that were handled but 
not trained on the task. In the second cohort, rats were trained with a post-training 
injection of saline or epinephrine, and these groups were also compared to untrained 
rats. To facilitate comparison between glucose and epinephrine, the data from the two 
cohorts were analyzed together by normalizing to the values obtained in the untrained 
rats. The optical densities of CREB and pCREB immunostaining, as well as 
pCREB:CREB ratios, were analyzed using two-way ANOVAs (age x training/treatment 
group) with post hoc Fisher PLSD tests where appropriate. 
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4.3. RESULTS 
4.3.1. Inhibitory Avoidance Training with Intrahippocampal Glucose Injections.  
Figure 4.1 shows training and 7-day retention latencies in young and old rats 
following inhibitory avoidance training and post-training intrahippocampal microinfusions 
of aCSF (Ns = 7 and 9 for young and old rats, respectively) or glucose (Ns = 8 and 11 
for young and old rats, respectively). Kruskal–Wallis analyses of variance revealed a 
significant group effect on retention latencies (p < .01) but not on training latencies. 
Post-hoc Mann-Whitney U-tests showed that the old rats injected with glucose had 
significantly higher 7-day retention latencies compared to those of old rats that had 
received aCSF injections (p < .05). The higher latencies seen in the old rats treated with 
glucose were similar to those of young rats, with the group medians reaching the ceiling 
600 sec maximum in each case. Figure 4.2 illustrates infusion needle tip placements in 
the dorsal hippocampus for young and old rats. 
 
4.3.2. Inhibitory Avoidance Training for Immunohistochemistry Experiments. 
For the immunohistochemistry experiments, retention testing latencies were not 
assessed since rats were euthanized 30 min after training. There were no significant 
differences in training latencies; the medians ranged from 5.5 – 7 sec across all groups 
(data not shown). Two old rats failed to cross into the dark chamber within two minutes 
and were not included in the study. Only two other rats had training latencies greater 
than 20 sec (40 and 120 sec in the young epinephrine and old glucose groups, 
respectively). 
 
4.3.3. CREB and pCREB Immunostaining Following Training 
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 Immunostaining levels of pCREB and total CREB, as well as pCREB:CREB 
ratios, were examined in young and old rats 30 min after inhibitory avoidance training. 
Rats were analyzed in four treatment groups: untrained rats (Ns = 16 for both young 
and old) and trained rats receiving post-training injections of saline (Ns = 16), 
epinephrine (Ns = 8), or glucose (Ns = 8). 
 
4.3.3.1. Hippocampus: Dentate Gyrus. 
 Figure 4.3 (A and B) shows the results for pCREB immunostaining in the dentate 
gyrus region of the hippocampus. A two-way ANOVA revealed a main effect of 
training/treatment on pCREB staining (F(3,88) = 7.51, p < .001). In young rats, training 
increased pCREB staining as compared to values in untrained rats. The increase was 
evident in all three trained groups that received post-training injections of saline, 
epinephrine, or glucose (ps < .05 vs. untrained where ps refer to the results of post-hoc 
comparisons). In old rats, training did not result in increased pCREB staining, as evident 
in the comparison of trained rats that received saline vs. untrained rats. Of particular 
interest here is the finding that post-training administration of glucose and epinephrine 
in aged rats significantly enhanced pCREB staining compared to both the untrained and 
saline groups (ps < .05).  
 There was a main effect of age (F(1,88) = 7.90, p < .01) on CREB immunostaining 
in the dentate gyrus (Figure 4.3C). However, post-hoc tests revealed no significant 
differences between young and old untrained rats. Neither training nor treatments with 
epinephrine or glucose significantly altered CREB staining in young or old rats (F(3,88) = 
0.31, p > 0.2). 
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There was a main effect of training/treatment (F(3,88) = 8.60, p < .0001) on 
pCREB:CREB ratios in the dentate gyrus (Figure 4.3D). In young rats, training resulted 
in increased pCREB:CREB ratios, with higher pCREB:CREB ratios in rats receiving 
post-training injections of saline, epinephrine, or glucose (ps < .01 vs. untrained). 
However, training had no effect in old rats, as evident by similar pCREB:CREB ratios 
between untrained rats and those receiving post-training saline injections. Interestingly, 
post-training administration of glucose but not epinephrine led to increased 
pCREB:CREB ratios compared to both untrained and saline-injected rats (ps < .01). 
 
4.3.3.2. Hippocampus: Area CA3. 
 In contrast to the results seen in dentate gyrus, there were no effects of training 
or treatments with epinephrine or glucose on pCREB staining (F(1,88) = 2.99, p > 0.2; 
Figure 4.4A and 4.4B) or on pCREB:CREB ratios (F(3,88) = 0.10, p > 0.2; Figure 4.4D) in 
area CA3. CREB staining in area CA3 decreased with age (F(1,88) = 24.21, p < .0001), 
with significantly lower levels in old compared to young untrained rats (p < .0001), but 
did not vary by training or treatments (F(3,88) = 0.23, p > 0.2; Figure 4.4C). 
 
4.3.3.3. Hippocampus: Area CA1. 
The results for area CA1 (Figure 4.5) were very similar to those for the dentate 
gyrus, and thus are not presented in detail here. The major exception was in the pCREB 
results for old rats. Specifically, glucose significantly enhanced pCREB staining 
compared to both the untrained and saline groups (ps < .05). Epinephrine was less 
effective, significantly enhancing pCREB staining compared to untrained (p < .05) but 
not saline-injected rats. 
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4.3.3.4. Basolateral Amygdala. 
Figure 4.6 (A and B) shows the results for pCREB immunostaining in the 
basolateral nucleus of the amygdala. There was a main effect of training/treatment on 
pCREB staining (F(3,88) = 5.87, p < .01). In young rats, training significantly enhanced 
pCREB staining; the trained groups that received saline, glucose or epinephrine all had 
higher pCREB staining compared to untrained rats (ps < .01). Epinephrine and glucose 
did not enhance pCREB levels beyond those attained after training plus saline. In old 
rats, the trained saline rats had slightly higher levels of pCREB expression than did 
untrained rats, but this was not a significant difference. Interestingly, in old rats, 
epinephrine but not glucose augmented pCREB expression to levels significantly above 
those of untrained rats (p < .05). 
There was a main effect of age (F(1,88) = 21.41, p < .0001) on CREB 
immunostaining, with significantly lower CREB staining in old compared to young 
untrained rats (p < .05; Figure 4.6C). However, neither training nor treatments 
significantly altered CREB staining in young or old rats (F(3,88) = 0.23, p > 0.2). 
The results obtained with pCREB:CREB ratios (Figure 4.6D) were similar to 
those seen with pCREB alone. There was a main effect of training/treatment (F(3,88) = 
7.04, p < .001). Compared to the ratios of untrained young rats, pCREB:CREB ratios 
increased with training followed by saline, glucose or epinephrine (ps < 01). In old rats, 
the ratios also increased above untrained values but only significantly so for the 
epinephrine-treated group (p < .05), though there was a trend toward enhancement in 
the glucose group (p < .06). 
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4.3.3.5. Lateral Amygdala. 
 The results in the lateral amygdala (data not shown) were very similar to those in 
the basolateral amygdala for pCREB, CREB, and pCREB:CREB ratios, and are thus not 
presented in detail here. 
 
4.3.3.6. Piriform Cortex. 
 There were no main effects of age (Fs(1,88) < 0.52), training, or treatment (Fs(3,88) 
< 0.09) on pCREB, CREB, or pCREB:CREB ratios in the piriform cortex (data not 
shown). 
 
4.3.3.7. Summary of Immunohistochemistry Results. 
 Table 4.1 summarizes the effects of epinephrine and glucose on modulating 
CREB phosphorylation across brain regions. 
 
4.4. DISCUSSION 
4.4.1. Age-Related Memory Impairments and Reversal by Intrahippocampal Glucose 
There are two main behavioral findings reported here. The first is that memory 
was impaired in old rats relative to young rats at 7 days after inhibitory avoidance 
training. These findings replicate past results, which showed that age-related 
impairments in memory after training on inhibitory avoidance training emerge with time 
(Gold et al., 1982; Zornetzer et al., 1982), i.e. old rats forget more rapidly than do young 
rats. Of note, differences in perception of the foot shock do not account for the findings 
(Foster and Kumar, 2007; Frye et al., 2010; Gold et al., 1982; Morris et al., 2010). The 
training conditions utilized in the present studies are the same as those for which 
systemic administration of epinephrine or glucose enhances memory (Morris et al., 
 92 
2010; Sternberg et al., 1985). Thus, the training conditions used to evaluate CREB 
activation were appropriate for showing age-related impairments in memory and in 
modulation of memory. 
The second main behavioral finding is that post-training injections of glucose 
directly into the hippocampus enhance later memory in aged rats. When drugs are 
administered after training, as here, effects on later memory for the learned experience 
cannot be attributed to alterations in non-mnemonic factors such as sensory, motor, or 
motivational variables (Gold, 2008; Gold and Korol, 2010; McGaugh, 1989, 2000). 
These results complement our previous findings that systemic epinephrine or glucose 
administration can enhance memory in aged animals in several settings, including when 
administered after training in both rodents (Morris et al., 2010; Sternberg et al., 1985) 
and humans (Manning et al., 1992).  
To our knowledge, this is the first example of a direct brain injection enhancing 
memory in aged rats using a post-training design. Previous work in young rats has 
shown that direct infusions of glucose into the lateral ventricles or into specific brain 
areas, including the medial septum, hippocampus, and amygdala, enhance memory 
(Canal et al., 2005; Pych et al., 2006; Ragozzino et al., 1996, 1998; Schroeder and 
Packard, 2003; Stefani and Gold, 1998; Stefani et al., 1999). Together with the present 
results, these findings are consistent with the idea that glucose acts directly in the brain, 
rather than in the periphery, to enhance memory in young and old rats. 
 
4.4.2. Age-Related Differences in CREB and pCREB Expression at Baseline and in 
Response to Training. 
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Compared to levels in young rats, baseline CREB levels were significantly 
depressed in area CA3 and in the basolateral and lateral amygdala of old compared to 
young untrained rats. The age-related decreases in baseline CREB levels were not 
evident in area CA1, the dentate gyrus, or piriform cortex. These results replicate those 
we described previously, where age-related decreases in CREB at baseline were 
evident in area CA3 and the amygdala, but not other brain regions tested (Morris and 
Gold, 2012a). More generally, age-related decreases in CREB expression observed 
here are also consistent with the findings of previous studies (Brightwell et al., 2004; 
Countryman and Gold, 2007; Trofimiuk et al., 2010).  
In addition to decreases in CREB expression in some brain areas, there were 
also significant age-related differences in CREB phosphorylation in response to training. 
In young rats, training with a post-training saline injection enhanced CREB 
phosphorylation compared to untrained controls. The increased pCREB values after 
training were region-specific, occurring in the dentate gyrus, area CA1, and the 
basolateral and lateral amygdala, but not in area CA3 or the piriform cortex. This same 
pattern of anatomical localization of CREB activation was seen previously in response 
to training without post-training injection of saline or other treatment (Morris and Gold, 
2012a). Thus, it appears that the pCREB activation after training observed here in the 
saline controls is a response to training and not to the stress of injection.  
In contrast to the results seen in young rats, pCREB levels in old rats were not 
responsive to training in any brain region tested. These results match those described 
previously, in which there were age-related deficits in CREB phosphorylation in the 
hippocampus and amygdala in response to training (Morris and Gold, 2012a). The 
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findings are also similar to the age-dependent deficits in hippocampal CREB activation 
and associated memory impairments after training on other hippocampus-sensitive 
tasks (Countryman and Gold, 2007; Kudo et al., 2005; Monti et al., 2005; Porte et al., 
2008a; Xu et al., 2010). Together, these results suggest that old rats are deficient in 
their ability to activate CREB in the hippocampus and amygdala in response to training. 
These are brain regions associated with inhibitory avoidance learning and modulation of 
that learning (Cammarota et al., 2008; Canal and Gold, 2007; Izquierdo et al., 1992, 
2002; Jobim et al., 2012; McGaugh et al., 2002; McIntyre et al., 2005; McReynolds et 
al., 2010; Milekic et al., 2007; Rossato et al., 2004). Using compromised CREB 
activation as a measure of functional integrity, the hippocampus and amygdala are 
therefore brain regions in which function impaired by age may contribute to the rapid 
forgetting seen in aged rats. 
 
4.4.3. Modulation of CREB Phosphorylation by Glucose and Epinephrine. 
In young rats, neither epinephrine nor glucose resulted in activation of CREB in 
the hippocampus or amygdala beyond the levels produced by training alone. 
Apparently, then, in young rats, the foot shock used during training was adequate to 
increase pCREB to levels that were not sensitive to further enhancement by these 
modulators of memory formation. The findings that a single foot shock was sufficient to 
increase pCREB expression in the hippocampus and amygdala are comparable to 
findings reported by others after inhibitory avoidance training (Bernabeu et al., 1997; 
Cammarota et al., 2000; Izquierdo et al., 2002; Taubenfeld et al., 1999; Viola et al., 
2000) and after training in other avoidance tasks (Bilang-Bleuel et al., 2002; Impey et 
al., 1998; Kogan and Richter-Levin, 2008; Porte et al., 2008b; Stanciu et al., 2001; 
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Trifilieff et al., 2006). The question of whether activation of CREB is associated with 
enhancement of memory in young rats was not addressed in the present experiments. 
Note that the training conditions used here produced maximal memory scores (600 sec) 
in young rats with or without treatments. Because a ceiling effect interfered with 
demonstrations of possible enhancement of memory, the experimental conditions did 
not permit assessment of the possibility that modulators of memory might activate 
CREB in a manner associated with enhancement of memory. Although these 
treatments did not augment CREB activation beyond that attained with training alone in 
young rats, it will be important to determine whether CREB activation plays a role in 
enhancement of memory with epinephrine or glucose in young rats. 
In old rats, pCREB responses to training per se were not evident in the 
hippocampus or amygdala. However, treatment with either epinephrine or glucose 
augmented those responses under conditions where the treatments would enhance 
memory (Morris et al., 2010; Sternberg et al., 1985). While both epinephrine and 
glucose enhance memory in aged rats, the effects are generally more robust with 
glucose than with epinephrine (Morris et al., 2010). The pCREB results in the dentate 
gyrus and CA1 region of the hippocampus reflect this best. In these brain regions, 
glucose was somewhat more effective than was epinephrine at augmenting CREB 
activation. These findings suggest that activation of CREB in the hippocampus parallels 
and may contribute to memory enhancement by epinephrine and glucose in aged rats. 
Related evidence indicates that glucose augments training-related release of 
acetylcholine in the hippocampus of young adult rats (Gold, 2003; Kopf et al., 2001; 
Morris et al., 2010; Ragozzino and Gold, 1995; Ragozzino et al., 1996, 1998) and is 
 96 
more effective than epinephrine at increasing acetylcholine release during training in the 
hippocampus of aged rats (Morris et al., 2010). Thus, one possibility is that glucose 
enhances CREB phosphorylation through activation of the cholinergic system. Related 
to this possibility is evidence that fimbria-fornix lesions, which disrupt cholinergic 
innervation to the hippocampus (Erb et al., 1997; Nilsson and Björklund, 1992), also 
disrupt hippocampal CREB activation and impair memory for inhibitory avoidance 
(Taubenfeld et al., 1999, 2001). Acetylcholine can result in phosphorylation of CREB 
through binding to muscarinic 3 (M3) receptors (Greenwood and Dragunow, 2002, 2010) 
or nicotinic α7 receptors (Bitner et al., 2007, 2010; Gubbins et al., 2010; Tietje et al., 
2008). Actions mediated by α7 receptors are somewhat more likely because these 
receptors are highly expressed in the hippocampus (Séguéla et al., 1993; Tribollet et al., 
2004), while M3 receptors are expressed at low levels in the hippocampus (Buckley et 
al., 1988; Levey et al., 1994; Vilaró et al., 1993). 
While post-training injections of either epinephrine or glucose increased pCREB 
activation in old rats, only epinephrine did so significantly in the amygdala. Thus, the 
rank order of efficacy of epinephrine and glucose in augmenting pCREB levels in the 
amygdala does not match their effects on memory (Morris et al., 2010). These findings 
suggest that activation of the hippocampus may contribute more than does activation of 
the amygdala to the enhancement of memory in old rats by epinephrine and glucose. 
Epinephrine, like glucose, may enhance CREB phosphorylation through activation of 
the cholinergic system. However, because epinephrine is less effective than glucose at 
enhancing acetylcholine release in the hippocampus of old rats, epinephrine may work 
through additional mechanisms to activate CREB. Particularly in the amygdala, 
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epinephrine may enhance CREB phosphorylation through the activation of 
neurotransmitters other than acetylcholine, such as norepinephrine. Noradrenergic 
mechanisms in the amygdala appear to be important for memory modulation generally 
and for enhancement of memory by epinephrine in particular (Ferry and McGaugh, 
2000; McGaugh, 2004; McGaugh et al., 2002; McIntyre et al., 2003). In young adult 
rats, epinephrine or foot shock produces rapid and sustained increases in 
norepinephrine release in the amygdala (Canal et al., 2008; Galvez et al., 1996; Gold 
and van Buskirk, 1978a,b; McIntyre et al., 2002; McReynolds et al., 2010; Quirarte et 
al., 1998; Williams et al., 1998). In addition, injections of adrenergic antagonists into the 
amygdala attenuate the memory-enhancing effects of epinephrine (Liang et al., 1986, 
1990; McIntyre et al., 2005; McReynolds et al., 2010; Williams and McGaugh, 1993). 
Importantly, it is not likely that noradrenergic signaling mediates enhancement of 
memory by glucose. Peripheral glucose administration prior to spontaneous alternation 
testing significantly improved working memory scores but had no effect on hippocampal 
norepinephrine release (Men et al., 1999). In contrast, glucose significantly enhanced 
hippocampal acetylcholine release and improved memory under similar and related 
conditions (Ragozzino et al., 1996, 1998; Stefani and Gold, 2001). Noradrenergic 
signaling in the amygdala and other brain areas leads to activation of cAMP-mediated 
signaling pathways, including CREB phosphorylation (Barros et al., 1999; Chen et al., 
2007; Davies et al., 2004; Ferry et al., 1999; Patel et al., 2010; Yuan et al., 2000). 
These findings suggest that epinephrine, unlike glucose, may modulate CREB 
phosphorylation by increasing norepinephrine release in the amygdala. This hypothesis 
fits well with the current results, in which epinephrine significantly enhanced CREB 
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phosphorylation in the amygdala of old rats, presumably without associated increases in 
blood glucose. However, examining norepinephrine release in the amygdala and 
hippocampus of old rats is an important future direction. 
 
4.4.4. Conclusions. 
The present experiments support the hypothesis that age-related deficits in blood 
glucose responses to endogenous epinephrine release may alter neurobiological 
processes related to memory formation. In old rats, increases in circulating epinephrine 
in response to training or stress may represent an impaired physiological mechanism in 
the liver for producing increases in blood glucose levels. The alterations in this 
neuroendocrine response could change the relative contributions of neurotransmitters 
and memory systems involved in cognitive processing. Although both epinephrine and 
glucose can support improved memory in old rats, both peripheral and intrahippocampal 
glucose administration are particularly effective in this regard. Thus, examining the 
neural mechanisms underlying glucose-mediated memory processes may provide 
greater insight into strategies for reversing age-related cognitive decline. 
 
4.5. FIGURES 
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Figure 4.1. Effects of age and intrahippocampal glucose administration on 7-day inhibitory 
avoidance retention latencies. 
(A) There were no significant differences in training latencies across groups. (B) Old rats 
receiving post-training intrahippocampal injections of aCSF had significantly lower 7-day 
retention latencies compared to young rats receiving either aCSF or glucose injections. Post-
training glucose injections reversed age-related impairments, improving retention latencies in 
old rats to levels seen in young rats. (*) p < .05 vs. old aCSF group. i.q.r. = interquartile range. 
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Figure 4.2. Infusion sites targeting the dorsal hippocampus in young and old rats. 
Filled circles represent tips of infusion tracts. Numbers refer to distance in mm posterior to 
bregma. Adapted with permission from Paxinos and Watson (2005). 
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Figure 4.3. Age-, training-, and treatment-associated differences in pCREB and CREB 
immunoreactivity in the dentate gyrus of the hippocampus. 
(A) Representative photomicrographs of pCREB immunostaining. Scale bar = 100 microns. (B) 
Old rats had training-related deficits in pCREB activation, which were attenuated by epinephrine 
and glucose. (*) p < .05 vs. young untrained group. (**) ps < .01 vs. young untrained group. (+) 
ps < .05 vs. old untrained and saline groups. (C) There were significantly lower CREB levels in 
old compared to young rats. (D) Old rats had training-related deficits in pCREB:CREB ratios, 
which were attenuated by glucose. (**) ps < .01 vs. young untrained group. (++) ps < .01 vs. old 
untrained and saline groups. 
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Figure 4.4. Age-, training-, and treatment-associated differences in pCREB and CREB 
immunoreactivity in area CA3 of the hippocampus. 
(A) Representative photomicrographs of pCREB immunostaining. Scale bar = 100 microns. (B) 
There were no significant age-, training-, or treatment-related differences in pCREB levels. (C) 
There were significantly lower CREB levels in old compared to young rats. (D) pCREB:CREB 
ratios were significantly elevated in old compared to young rats. 
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Figure 4.5. Age-, training-, and treatment-associated differences in pCREB and CREB 
immunoreactivity in area CA1 of the hippocampus. 
(A) Representative photomicrographs of pCREB immunostaining. Scale bar = 100 microns. (B) 
Old rats had training-related deficits in pCREB activation, which were attenuated by epinephrine 
and glucose. (**) ps < .01 vs. young untrained group. (+) ps < .05 vs. old untrained and saline 
groups. (C) There were significantly lower CREB levels in old compared to young rats. (D) Old 
rats had training-related deficits in pCREB:CREB ratios, which were attenuated by glucose. (**) 
ps < .01 vs. young untrained group. (+) ps < .05 vs. old untrained and saline groups. 
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Figure 4.6. Age-, training-, and treatment-associated differences in pCREB and CREB 
immunoreactivity in the basolateral nucleus of the amygdala. 
(A) Representative photomicrographs of pCREB immunostaining. (B) Old rats had training-
related deficits in pCREB activation, which were attenuated by epinephrine. (**) ps < .01 vs. 
young untrained group. (+) p < .05 vs. old untrained group. Scale bar = 50 microns. (C) There 
were significantly lower CREB levels in old compared to young rats. (D) Old rats had training-
related deficits in pCREB:CREB ratios, which were attenuated by epinephrine. (**) ps < .01 vs. 
young untrained group. (+) p < .05 vs. old untrained group. 
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Table 4.1. Effects of epinephrine and glucose on modulating training-related CREB 
phosphorylation. 
 
 OLD RATS 
 EPINEPHRINE GLUCOSE 
pCREB   
DG ✓ ✓ 
CA3   
CA1 ✓ ✓ 
BLA ✓  
LA ✓  
PIR   
pCREB:CREB   
DG  ✓ 
CA3   
CA1  ✓ 
BLA ✓  
LA ✓  
PIR   
 
 
✓denotes significant effect versus untrained rats. Brain regions analyzed were dentate gyrus 
(DG), area CA3, and area CA1 of the hippocampus, basolateral (BLA) and lateral (LA) 
amygdala, and piriform cortex (PIR). 
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CHAPTER 5: GLUCOSE ATTENUATES IMPAIRMENTS IN MEMORY AND CREB 
ACTIVATION PRODUCED BY AN α4β2 BUT NOT AN α7 NICOTINIC RECEPTOR 
ANTAGONIST 
Glucose improves memory for a variety of tasks when administered to rats and 
mice near the time of training. Prior work indicates glucose may enhance memory by 
increasing the synthesis and release of the neurotransmitter acetylcholine in the brain. 
To investigate if specific acetylcholine receptor subtypes may mediate some of the 
memory-enhancing actions of glucose, we examined the effects of subtype-specific 
nicotinic acetylcholine receptor antagonists on memory in Fischer-344 rats and also 
examined the ability of glucose to reverse drug-induced impairments. Pre-training 
peripheral injections of methyllycaconitine (MLA) or dihydro-beta-erythroidine (DHβE), 
which are specific α7 and α4β2 nicotinic receptor antagonists, respectively, dose-
dependently impaired retention latencies in an inhibitory avoidance task when tested 7-
days but not 1 hour after training. Immediate post-training glucose injections attenuated 
the impairments, but were more effective in attenuating the DHβE-induced impairments. 
Likewise, peripheral or direct intrahippocampal injections of MLA or DHβE dose-
dependently impaired alternation spatial working memory scores on a spontaneous 
alternation task. Concurrent administration of glucose reversed DHβE- but not MLA-
induced impairments. CREB phosphorylation downstream of cholinergic signaling was 
assessed 30 minutes after spontaneous alternation testing with intrahippocampal drug 
infusions. Both MLA and DHβE impaired hippocampal CREB phosphorylation, with 
glucose reversing DHβE but not MLA-induced deficits. The effectiveness of glucose in 
reversing DHβE- but not MLA- induced impairments in behavioral performance and 
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CREB phosphorylation suggests that activation of α7 receptors may play an important 
role in memory enhancement by glucose. 
 
5.1. INTRODUCTION 
In humans and rodents, rises in blood glucose in response to stressful or 
emotional stimuli mediate memory improvement for the associated events. Likewise, 
glucose administration prior to or shortly after an event can increase its salience, 
converting a relatively unimportant event to a memorable one (Gold and Korol, 2010; 
Korol and Gold, 1998, 2007; Messier, 2004). In young adult rodents, increases in blood 
glucose enhance memory in a wide variety of behavioral tasks, ranging from tests of 
spatial working memory to assessments of memory at long intervals after training (cf. 
Gold, 2008). Glucose can also reverse age-related memory impairments in these same 
tasks, improving performance in old rats to the levels seen in young rats (Gold, 2005; 
McNay and Gold, 2001; Morris et al., 2010; Salinas and Gold, 2005). 
Glucose is thought to work directly in the brain to enhance cellular and molecular 
memory processes, perhaps mediated by enhanced aerobic glycolysis and lactate 
production in astrocytes (Newman et al., 2011; Suzuki et al., 2011). Previous work 
suggests that systemically- or centrally-administered glucose may enhance memory by 
augmenting central release of the neurotransmitter acetylcholine. A number of 
microdialysis studies show that both peripheral and direct intrahippocampal glucose 
administration augment training-related acetylcholine release in the hippocampus, 
concurrent with memory enhancement (Kopf et al., 2001; Morris et al., 2010; Ragozzino 
and Gold, 1995; Ragozzino et al., 1996, 1998). These effects on acetylcholine release 
appear to be regionally specific and do not occur in animals at rest (Ragozzino et al., 
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1996, 1998), suggesting that glucose supports enhanced acetylcholine release in 
particular brain areas where it is needed to facilitate memory processes. 
An open question is whether the memory-improving actions of glucose rely on 
signaling through some acetylcholine receptor subtypes more than others. Acetylcholine 
activates both muscarinic and nicotinic acetylcholine receptors. The subtypes of these 
receptors have diverse functions and variable expression patterns throughout the brain. 
Previous work indicates that peripheral injections of general muscarinic and nicotinic 
antagonists impair performance in a number of behavioral memory paradigms, including 
inhibitory avoidance and spontaneous alternation tasks, and that co-administration of 
glucose attenuates these impairments (Blanchard and Duncan, 1997; Kopf and Baratti, 
1994; Ragozzino and Gold, 1991; Ragozzino et al., 1994a; Stone et al., 1988, 1991, 
1995). These results imply a lack of regional and receptor specificity in glucose’s 
actions, suggesting that glucose could compensate for deficits in muscarinic receptors 
by promoting signaling through nicotinic receptors, and vice versa. However, the results 
are difficult to interpret because of the wide-ranging effects of these drugs throughout 
the body and brain, including effects not specific to memory processes. 
The emergence of drugs targeting specific acetylcholine receptor subtypes in the 
brain, as opposed to general muscarinic or nicotinic receptors, makes it possible to 
begin evaluating which receptor subtypes may be important to the memory-enhancing 
effects of glucose. Two nicotinic receptor subtypes, α4β2 and α7, possess the functional 
properties and regional distribution that make them potential mediators of glucose’s 
effects (Cincotta et al., 2008; Graef et al., 2011; Kenney and Gould, 2008; Levin et al., 
2006). Neuronal nicotinic receptors are ionotropic receptors composed of various 
 109 
combinations of five membrane-spanning subunits. Nine α (α2–α10) and three β (β2–
β4) subunits have been identified, making a large number of receptor subtype 
combinations possible. However, the heteromeric α4β2 and homomeric α7 receptor 
subtypes have garnered the most attention due to their high levels of expression in the 
brain and roles in a variety of cognitive processes. In many situations, α4β2 and α7 
receptors appear to function similarly. For example, a number of studies have utilized 
direct brain infusions of methyllycaconitine (MLA) or dihydro-β-erythroidine (DHβE), 
which are competitive antagonists for α7 and α4β2 receptors, respectively, to assess 
working memory performance in the radial arm maze. Infusions of either MLA or DHβE 
into the ventral or dorsal hippocampus, amygdala, or frontal cortex induced working 
memory impairments, with only minor dose-related differences between the drugs (Addy 
et al., 2003; Bettany and Levin, 2001; Chan et al., 2007; Levin et al., 2002; Nott and 
Levin, 2006). In other cases, there are distinct functional differences between the α4β2 
and α7 receptor subtypes. For instance, there are several studies indicating a specific 
role for α4β2 but not α7 receptors in mediating the effects of nicotine on enhancing 
memory for contextual fear conditioning (Davis and Gould, 2006, 2007; Davis et al., 
2007; Kenney et al., 2012). 
Recent evidence indicates that glucose and nicotinic acetylcholine receptors 
activate a similar downstream molecular signaling pathway related to memory 
formation. Specifically, cAMP response element binding protein (CREB) is a 
transcription factor widely implicated in the formation of long-lasting memory and long-
term changes in synaptic plasticity (Alberini, 2009; Benito and Barco, 2010; Carlezon et 
al., 2005; Morris and Gold, 2012a; Silva, 1998; Yin and Tully, 1996). A number of 
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studies indicate that nicotine administration activates CREB in a variety of neuronal cell 
types in both in vitro and in vivo models (Chang and Berg, 2001; Hu et al., 2002; 
Nakayama et al., 2001; Pascual et al., 2009; Tang et al., 1998). Likewise, glucose 
administration following inhibitory avoidance training reverses age-related memory 
impairments, with parallel activation of CREB phosphorylation. Consistent with the view 
of regional selectivity in the memory-enhancing actions of glucose, there is a high 
degree of regional variability in glucose-mediated increases in CREB phosphorylation, 
including within subregions of the hippocampus (Morris and Gold, 2012b). 
The following work examines the effects of the α7 antagonist MLA and the α4β2 
antagonist DHβE on memory processes in inhibitory avoidance and spontaneous 
alternation tasks, and also examines the ability of glucose to attenuate drug-induced 
impairments. The experiments utilize both peripheral and direct intrahippocampal 
injections, and include correlations with the expression of phosphorylated CREB 
(pCREB) in the hippocampus. 
 
5.2. METHODS 
5.2.1. Subjects. 
Young adult (3 to 4 mo.) male Fischer-344 rats ordered from Taconic Farms 
(Germantown, NY) were individually housed in translucent cages with a 12-h light/dark 
cycle (lights on at 07:00 h) and ad libitum access to food and water. Animal pain and 
discomfort were minimized, and all experiments were conducted in accordance with 
animal care guidelines established by the National Institute of Health and the University 
of Illinois, which is fully accredited (AAALAC). Rats were handled for 2-3 min each day 
on 5 consecutive days prior to behavioral training. 
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5.2.2. Preparation of drugs. 
Methyllycaconitine citrate salt hydrate (MLA) was obtained from Sigma-Aldrich 
(St. Louis, MO). Dihydro-β-erythroidine hydrobromide (DHβE) was obtained from Tocris 
Bioscience (Minneapolis, MN). MLA, DHβE, and glucose were dissolved in saline for 
intraperitoneal (i.p.) administration or in artificial cerebral spinal fluid (aCSF; 128 mM 
NaCl, 2.5 mM KCl, 1.3 mM CaCl2, 2.1 mM MgCl2, 0.9 mM NaH2PO4, 2.0 mM 
Na2HPO4, 1 mM glucose, pH 7.4) for intrahippocampal administration. The 1.0 mM 
glucose concentration in the aCSF is based on evidence that this level is seen at 
baseline in hippocampal extracellular fluid (McNay and Gold, 1999). 
 
5.2.3. Surgery and intrahippocampal drug infusions. 
Rats were deeply anesthetized with isoflurane and placed in a stereotaxic 
apparatus. Stainless steel guide cannulae (Plastics One, Roanoke, VA) were implanted 
bilaterally into the dorsal hippocampus [coordinates: - 3.2 mm from bregma; ± 2.5 mm 
lateral; - 1.4 mm deep from dura], according to the atlas of Paxinos and Watson (2005). 
Rats were monitored and allowed to recover for 7 days after surgery. Prior to training, 
microinfusion probes (Plastics One) were inserted through the guide cannulae to a point 
1 mm below the guide cannulae tips. Compounds were infused bilaterally into the dorsal 
hippocampus at a rate of 0.25 µl / min for 2 min. Infusion probes were left in place for an 
additional 1 min to allow solutions to diffuse away from the probe tips. 
 
5.2.4. Inhibitory avoidance training. 
All training and testing took place between 12:00 and 16:00 h. The inhibitory 
avoidance apparatus was a trough-shaped alleyway (91 cm long, 22.9 cm wide at the 
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top, 7.6 cm wide at the bottom, and 15.2 cm deep) divided into lit (31 cm) and dark (60 
cm) compartments by a sliding door that could be lowered through the floor. Each rat 
was placed in the lit chamber facing the door. When the rat turned completely around, 
the door was lowered to a height 2 cm above the floor. When the rat again turned 
toward the door, a timer was started to record the latency to enter the dark chamber (i.e. 
the training latency). Upon entering the dark chamber, the rat received a brief foot shock 
(0.2 mA, 0.4 sec) and the door was closed to prevent reentry into the lit chamber. After 
training or post-training injections, rats were returned to the holding cage. Retention 
latencies (max of 600 sec) were tested 7 days later using a similar procedure, but 
without the foot shock. MLA (0.5, 2, or 5 mg/kg) or DHβE (0.5, 2, or 5 mg/kg) were given 
i.p. 10 min prior to training. Glucose (250 mg/kg) was given i.p. immediately after 
training. 
 
5.2.5. Foot shock perceptual thresholds. 
10 min after i.p. injections of saline or 2 mg/kg MLA or DHβE, rats received a 
series of foot shocks (each 0.5-sec duration) beginning at 0.1 mA and increasing at 0.05 
mA increments with a 30 sec inter-shock interval until a jump response was induced. 
The lowest shock intensities that caused the rats to flinch and jump were recorded by 
two independent observers. 
 
5.2.6. Spontaneous alternation testing. 
All training took place between 12:00 and 16:00 h. Spontaneous alternation 
performance was assessed in a 4-arm plus-shaped black Plexiglas maze with an open 
ceiling. The dimensions of each arm were 45 cm L x 13 cm W x 7 cm H. The 
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dimensions of the central square-shaped area were 13 cm L x 13 cm W x 7 cm H. The 
training room contained numerous extramaze visual cues in the form of objects and wall 
decorations. Rats were placed in a random start arm and were allowed to freely 
traverse the maze for 20 min. The number and sequence of entries were recorded and 
alternation performance was calculated. An alternation consisted of visiting all four arms 
within overlapping sets of five arm visits. Using this procedure, the total number of 
possible alternations was equal to the number of arm entries minus 4. The percent 
alternation score is equal to (actual alternations/possible alternations) x 100. Chance 
performance on this task is 44%. Only data from rats that made at least 10 arm choices 
(6 possible alternations) were included in the analyses. For experiments with i.p. 
injections, MLA (0.5, 2, or 5 mg/kg) or DHβE (0.5, 2, or 5 mg/kg) were administered 
alone or in combination with glucose (250 mg/kg) 30 min prior to testing. For 
experiments with intrahippocampal injections, MLA (6.75, 13.5, or 27 μg/side) or DHβE 
(4, 8, or 20 μg/side) were infused alone or in combination with glucose (16.7 nmol/side) 
beginning 10 min prior to training. Some of the experiments with intrahippocampal 
injections (i.e. those illustrated in Figure 5.5) utilized a Latin square design in which 
each rat was tested on four separate occasions with a 3-day rest in between each test. 
Prior to each test, each rat received a single infusion of a drug, with doses administered 
in a counterbalanced order. 
 
5.2.7. Perfusion and Brain Slicing. 
For analysis of infusion probe placement, brains were collected within two days 
of the end of behavioral testing. For pCREB immunohistochemistry, brains were 
collected 30 min after spontaneous alternation testing. Rats were deeply anesthetized 
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with an overdose injection of sodium pentobarbital (i.p.; Sigma-Aldrich) and then 
perfused intracardially with 80 ml of 0.1 M phosphate-buffered saline followed by 80 ml 
of 4% paraformaldehyde in 0.1 M phosphate buffer. Rats were decapitated and the 
brains were removed and placed into 4% paraformaldehyde in 0.1 M PB for ~72 hrs. 
The brains were transferred to 20% glycerol in 0.1 M PBS for ~48 hrs. For probe 
placement analysis, frozen sections (40 µM) containing the probe infusion tracts were 
collected at -30o C with a Leica 1800 cryostat (Leica Microsystems, Wetzlar, Germany). 
Sections were mounted onto gelatin-coated slides and stained with cresyl violet to 
visualize probe placements, which were determined using a dissection microscope. For 
immunohistochemistry, frozen sections (40 µM) just posterior to the injection site were 
collected at -30o C with a Leica 1800 cryostat. Slices were stored in a cryopreservative 
solution (250 mM 40 KD polyvinylpyrrolidone, 880 mM sucrose, 30% v/v ethylene 
glycol, 50 mM sodium phosphate) at -20o C. 
 
5.2.8. Immunohistochemistry. 
All steps took place at room temperature and all reactions were performed in 
duplicate. Slices were washed three times for 10 min each time in 0.05 M PBS initially 
and between all subsequent steps. Slices were first incubated in blocking solution (1% 
H2O2, 1% normal goat serum, 0.02% triton x-100, 0.05 M PBS) for 10 min. They were 
transferred to a pre-incubation solution (2% NGS, 0.4% triton x-100, 0.05 M PBS) for 20 
min and then incubated overnight in a solution (1% NGS, 0.4% triton x-100, 0.05 M 
PBS) containing a rabbit primary antibody for Ser-133 phosphorylated CREB (Millipore, 
Billerica, MA) diluted 1:4000. The next day, the slices were placed for 1 hr in a solution 
(1% NGS, 0.2% triton x-100, 0.05 M PBS) containing a goat anti-rabbit biotinylated 
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secondary antibody (Santa Cruz, Santa Cruz, CA). They were next incubated for 30 min 
with ABC reagent (Vector, Burlingame, CA) in 0.05 M PBS, followed by incubation with 
DAB substrate (Vector) for 4 min. Slices were mounted onto slides and allowed to dry 
overnight. The next morning, slices were dehydrated with a graded ethanol series of 
washes, then coverslipped using DPX mountant (Sigma-Aldrich). 
 
5.2.9. Image Acquisition and Analysis. 
Sections were imaged using a Leica DM 6000B/CTR6000 light microscope and a 
Leica DFC350 FX video camera, which was interfaced to a PC computer. This system 
was used in conjunction with Image-Pro software (Media Cybernetics, Inc., Bethesda, 
MD) for image acquisition and for correction of unevenness in illumination across 
images. Image J software (NIH, Bethesda, MA) was used to quantify the integrated 
optical density of pCREB staining in area CA1 and the dentate gyrus of the 
hippocampus. A statistical thresholding method in Image J was used to ensure that only 
specifically labeled cells were being measured. For each image, the optical density of a 
nearby region with no or little specific staining was calculated and used for background 
subtraction. 
 
5.2.10. Statistical Analyses. 
All analyses were performed using Statview software. Inhibitory avoidance 
behavioral results were analyzed using a non-parametric Kruskal-Wallis one-way 
analysis of variance, followed by Mann-Whitney tests for individual comparisons. The 
spontaneous alternation behavioral results (except those noted below) and the optical 
densities of pCREB immunostaining were analyzed using one-way ANOVAs with post 
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hoc Fisher PLSD tests where appropriate. The spontaneous alternation behavioral 
results that utilized a Latin square design were analyzed using repeated measures 
ANOVA with post hoc Fisher PLSD tests where appropriate. Correlations between 
behavioral results and protein expression were determined by simple linear regression. 
 
5.3. RESULTS 
5.3.1. Inhibitory Avoidance Training with Peripheral Injections of Drugs. 
Figure 5.1 shows the effects of peripherally-administered nicotinic antagonists on 
retention of inhibitory avoidance training. Drugs were administered 10 min prior to 
training. There was a significant main effect of MLA on 7-day retention latencies (H(3,28) 
= 12.02, p < .01). Both the 2 and 5 mg/kg doses of MLA significantly depressed 7-day 
retention latencies compared to those of saline-injected controls (ps < .05). The 2 mg/kg 
dose was more effective, significantly depressing 7-day retention latencies compared to 
the 5 mg/kg dose (p < .05). There was also a significant main effect of DHβE on 7-day 
retention latencies (H(3,28) = 9.60, p < .05). The 2 and 5 mg/kg doses of DHβE were 
similarly effective at depressing 7-day retention latencies compared to saline controls 
(ps < .05). Neither MLA nor DHβE significantly altered training latencies. 
To examine if glucose could attenuate drug-induced impairments in 7-day 
retention latencies, saline or 2 mg/kg MLA or DHβE were administered 10 min before 
inhibitory avoidance training in combination with immediate post-training injections of 
saline or glucose (250 mg/kg). The results are shown in Figure 5.2. Both MLA-saline 
and DHβE-saline significantly reduced 7-day retention latencies compared to saline-
saline controls (ps < .01). Peripheral glucose administration attenuated these drug-
induced impairments, but was more effective in reversing DHβE-induced deficits. In the 
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MLA-glucose group, retention latencies were significantly higher than those in the MLA-
saline group, but still significantly reduced compared to those in saline-saline controls 
(ps < .05). By comparison, retention latencies in the DHβE-glucose group were similar 
to those in the saline-saline group (p > 0.5), with the group median reaching the 600 sec 
maximum. Training latencies were not significantly different across groups. 
MLA or DHβE-induced impairments in retention latencies may reflect an inability 
of rats to acquire the learned response. To examine this possibility, two experiments 
were performed. The first experiment assessed retention latencies using a shorter 
training-testing interval. Saline or 2 mg/kg MLA or DHβE was injected 10 min prior to 
training, and retention latencies were tested 1 hr later. All three groups had median 1-hr 
retention latencies at the maximum of 600 sec, with no significant differences among 
groups (data not shown). The second experiment examined the effects of the drugs on 
foot shock perceptual thresholds. Injections of 2 mg/kg MLA or DHβE 10 min prior to 
foot shock did not significantly alter flinch or jump thresholds compared to those of 
saline-injected rats. The flinch thresholds were 0.26 ± 0.01 mA (mean ± s.e.m.) for all 
groups. Jump thresholds ranged from 0.63 ± 0.03 mA in the saline and DHβE groups to 
0.65 ± 0.03 in the MLA group. 
 
5.3.2. Spontaneous alternation testing. 
5.3.2.1. Peripheral injections of drugs. 
Figure 5.3 shows the effects of peripherally-administered nicotinic antagonists on 
spontaneous alternation scores. MLA or DHβE given 30 min before testing impaired 
alternation scores, with effective doses similar to those observed in the inhibitory 
avoidance task (F(3,28) = 3.09, p < .05 for MLA; F(3,28) = 3.34, p < .05 for DHβE). For the 
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MLA experiment, the intermediate dose of 2 mg/kg, but not lower or higher doses, 
significantly reduced alternation scores compared to saline-injected controls (p < .05). In 
contrast, MLA had no significant effect on the number of arm entries during testing, 
which ranged from 24.6 ± 2.8 (mean ± s.e.m.) in the saline group to 26.1 ± 2.6 in the 2 
mg/kg MLA group. For the DHβE experiment, doses of 2 and 5 mg/kg were about 
equally effective at impairing alternation scores compared to saline controls (ps < .05). 
The number of arm entries decreased with increasing doses of DHβE, ranging from 
mean values of 23.3 ± 1.3 in the saline group to 18.5 ± 1.9 in the 5 mg/kg DHβE group. 
However, this was not a statistically significant effect. 
To determine if glucose could attenuate drug-induced impairments in 
spontaneous alternation scores, MLA or DHβE (2 mg/kg) was administered alone or in 
combination with glucose (250 mg/kg) 30 min before testing (Figure 5.4). MLA and 
DHβE significantly impaired alternation scores compared to saline-injected controls (ps 
< .01). Glucose had no significant effect on attenuating MLA-induced deficits; rats 
treated with MLA-glucose had alternation scores similar to those in the MLA group (p > 
0.5) and significantly lower than those of saline controls (p < .05). However, glucose 
reversed DHβE-induced impairments in alternation performance, raising scores well 
above those of rats administered DHβE alone (p < .05). The number of arm entries 
were significantly reduced in the DHβE (17.5 ± 1.5) and DHβE-glucose (17.1 ± 0.8) 
groups compared to saline controls (23.4 ± 1.4; ps < .01). Therefore, the effect of 
glucose was restricted to DHβE effects on alternation scores and did not extend to drug 
effects on locomotor activity. The number of arm entries in the other groups were not 
significantly different from those in the saline group. 
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5.3.2.2. Intrahippocampal injections of drugs. 
 Figure 5.5 shows the effects of intrahippocampally-administered nicotinic 
antagonists on spontaneous alternation scores. To reduce the number of rats subjected 
to surgical procedures, a Latin square design was used here but not in subsequent 
experiments with glucose. Drugs were infused beginning 10 min before testing. Both 
MLA and DHβE infusions significantly impaired alternation scores (F(3,24) = 3.02, p < .05 
for MLA; F(3,24) = 3.17, p < .05 for DHβE). MLA doses of 6.75 and 13.5 µg/side were 
equally effective at impairing alternation scores compared to those of aCSF-injected 
controls (ps < .05). However, MLA lost its effectiveness in impairing alternation scores 
at the highest dose of 27 µg/side. DHβE was ineffective at the lowest dose of 4 µg/side, 
but significantly impaired alternation performance at higher doses of 8 and 20 µg/side 
(ps < .05 vs. aCSF). Neither MLA nor DHβE infusions significantly altered the number of 
arm entries. The mean numbers of arm entries were slightly lower than those seen with 
peripheral injections, ranging from 19.4 ± 2.8 to 23.1 ± 2.7 in the MLA experiment and 
19.1 ± 2.4 to 21.2 ± 1.4 in the DHβE experiment. 
The effects of intrahippocampal glucose on attenuating drug-induced deficits 
largely paralleled the results seen with peripheral injections. Glucose (16.7 nmol/side) 
was combined with the lowest effective doses of the nicotinic antagonists and infused 
10 min before alternation testing. As shown in Figure 5.6, glucose had no effect on 
attenuating MLA-induced impairments in alternation performance. Both the MLA and 
MLA-glucose groups had significantly depressed alternation scores (ps < .05 vs. aCSF), 
which were not significantly different from each other (p > 0.5). In contrast, glucose 
reversed DHβE-induced impairments in alternation scores. Although DHβE alone 
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produced significant deficits in alternation scores (p < .05 vs. aCSF), the DHβE-glucose 
group had similar scores compared to aCSF (p > 0.5). Unlike the pattern of results seen 
with peripheral injections of drugs, there was a trend for enhancement in alternation 
scores following infusion of intrahippocampal glucose alone (p < .06 vs. aCSF). The 
number of arm entries were similar across groups, ranging from 19.1 ± 3.0 in the DHβE-
glucose grouop to 24.6 ± 3.8 in the MLA-glucose group. 
 
5.3.3. pCREB Staining 
Immunostaining levels of pCREB were examined 30 min after spontaneous 
alternation testing in rats receiving intrahippocampal infusions of drugs (corresponding 
to Figure 5.6). As shown in Figure 5.7, pCREB staining levels in area CA1 paralleled the 
behavioral results. Both MLA and DHβE impaired pCREB staining compared to aCSF-
injected controls (ps < .05). Glucose reversed the DHβE- but not MLA-induced pCREB 
deficits (p > 0.5 DHβE vs. aCSF; p < .05 MLA vs. aCSF). Unlike with the behavioral 
results, there was no trend for enhancement of pCREB staining by intrahippocampal 
glucose alone (p > 0.5). In contrast to the results for area CA1, there were no significant 
effects of drug treatments on pCREB staining levels in the dentate gyrus (data not 
shown). 
As shown in Figure 5.8, there was a significant positive correlation between area 
CA1 pCREB staining levels and spontaneous alternation scores in rats receiving MLA-
glucose injections (r = 0.90, p < .01), and a trend for significance in rats receiving MLA 
alone (r = 0.69, p = .09). There were no correlations or trends in any of the other groups 
(ps > 0.2). 
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5.4. DISCUSSION 
5.4.1. Effects of nicotinic antagonists on memory. 
Peripheral injections of MLA or DHβE impaired memory when tested 7 days after 
inhibitory avoidance training, supporting the view that inhibition of cholinergic signaling 
through either α7 or α4β2 nicotinic receptors inhibits the formation of long-lasting 
memories. Previous studies in rats and mice have shown that pre-training peripheral 
administration of the centrally-acting nicotinic antagonist mecamylamine impairs later 
retention for inhibitory avoidance training, whereas the peripherally-acting nicotinic 
antagonist hexamethonium has no effect (Chiappetta and Jarvik, 1969; Glick and 
Greenstein, 1972; Goldberg et al., 1971; Ragozzino and Gold, 1991; Rush and Streit, 
1992). The present results extend these findings, suggesting that mecamylamine could 
exert its behavioral effects through inhibition of α4β2 and/or α7 receptors in the brain. 
In the present study, the administration of the drugs prior to instead of after 
inhibitory avoidance training leaves open the possibility that the drugs produced 
apparent amnesia by altering factors other than memory, such as attention, motivation, 
or sensorimotor processes. However, a few pieces of evidence indicate that behavioral 
differences due to effects on non-mnemonic variables are unlikely. First, neither MLA 
nor DHβE altered training latencies or thresholds for foot shock sensitivities, suggesting 
that these measures of sensorimotor processes were intact during training. Second, the 
high memory scores in MLA- or DHβE-injected rats tested 1 hr after training indicate the 
drugs did not interfere with the ability of the rats to learn and initially remember the 
training experience. However, differences between saline- and drug-injected groups 
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could have been masked by a ceiling effect, given that the median 1-hr retention 
latencies in all groups reached the maximum of 600 sec. 
Peripheral administration of MLA or DHβE also impaired performance in the 
spontaneous alternation task. These results were remarkably similar to the effects of the 
antagonists on retention performance in the inhibitory avoidance task, and were 
consistent with past findings showing that peripheral injections of mecamylamine, but 
not the peripherally acting hexamethonium, impair alternation performance (Ragozzino 
and Gold, 1991). In both the spontaneous alternation and inhibitory avoidance tasks, 
MLA-induced impairments followed a U-shaped pattern, in which the middle dose of 2 
mg/kg was most effective at impairing behavioral performance. In contrast, both 2 and 5 
mg/kg doses of DHβE were similarly effective at impairing performance in these 
behavioral tasks. The U-shaped pattern observed for MLA-induced deficits may relate to 
non-specific effects of the drug at higher doses. 
Direct infusions of MLA or DHβE into the dorsal hippocampus also impaired 
performance in the spontaneous alternation task, suggesting that the drugs work 
directly in the brain to impair spatial working memory processes. These results are 
consistent with prior behavioral studies of spatial working memory in the appetitive 
radial arm maze task, where infusions of MLA or DHβE directly into the hippocampus, 
amygdala, or frontal cortex, significantly increased working memory errors (Addy et al., 
2003; Bettany and Levin, 2001; Chan et al., 2007; Levin et al., 2002; Nott and Levin, 
2006). Interestingly, infusions of DHβE into the mediodorsal thalamic nucleus actually 
reduced working memory errors during radial arm maze testing (Cannady et al., 2009). 
Opposing effects in different brain regions of MLA or DHβE have also been observed in 
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trace fear conditioning (Raybuck and Gould, 2010), suggesting some regional variability 
in the actions of these drugs on learning and memory. In the present study, the effects 
of peripheral administration of MLA or DHβE on alternation scores were similar to those 
following intrahippocampal infusions, consistent with the possibility that the effects on 
memory of the peripherally-injected drugs may be mediated by hippocampal actions. 
 
5.4.2. Ability of glucose to reverse drug-induced memory impairments. 
In the inhibitory avoidance task, post-training injections of glucose were more 
effective at reversing DHβE- than at reversing MLA-induced memory deficits. Likewise, 
in the spontaneous alternation task, co-administration of glucose with the antagonists 
reversed DHβE- but not MLA-induced memory impairments, regardless of whether the 
drug/glucose combinations were administered peripherally or directly into the 
hippocampus. Previous work has shown that glucose reverses the memory-impairing 
effects of mecamylamine in both the inhibitory avoidance and spontaneous alternation 
tasks. However, glucose does not attenuate mecamylamine-induced decreases in 
locomotor activity, such as reductions in the number of arm entries during spontaneous 
alternation testing (Ragozzino and Gold, 1991; Ragozzino et al., 1994). In the present 
study, the results obtained with peripheral DHβE administration parallel those seen 
previously with mecamylamine. DHβE produced memory impairments and decreased 
the number of arm visits during spontaneous alternation testing; glucose attenuated the 
memory but not motor deficits. In contrast, MLA-induced memory impairments were not 
attenuated by glucose and followed a U-shaped dose-response function not seen 
previously with mecamylamine. MLA also had no significant effect on spontaneous 
alternation arm entries. The similarities in the behavioral effects of mecamylamine and 
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DHβE but not MLA may be a consequence of the functional properties of 
mecamylamine. Although mecamylamine is a nonselective nicotinic antagonist, it is a 
more potent and long-lasting inhibitor of β subunit-containing receptors (Papke et al., 
2001). Therefore, the behavioral effects of mecamylamine are more likely mediated by 
inhibition of α4β2 and/or other β subunit-containing receptors, as opposed to α7 
receptors.  
One possible explanation for why glucose reverses DHβE- but not MLA-induced 
behavioral deficits is that the memory-improving actions of glucose may rely more on 
α7- as opposed to α4β2-mediated signaling processes. For example, glucose may 
selectively up-regulate acetylcholine release in regions with high densities of α7 
receptors. Previous studies suggest that glucose is targeted to particular neural systems 
in response to task demands, where it may enhance local acetylcholine release (cf. 
Gold, 2004). There are high concentrations of α7 receptors in brain areas in which direct 
glucose injections lead to memory improvement. For example, the hippocampus has 
particularly dense levels of α7 receptors, which have a distinct regional localization and 
cell type distribution compared to other hippocampal acetylcholine receptors, including 
α4β2 receptors (Fabian-Fine et al., 2001; Gotti and Clementi, 2004; Tribollet et al., 
2004). By contrast, Pych et al. (2006) showed that injections of glucose into the dorsal 
striatum, which has relatively low levels of α7 receptors but an abundance of α4β2 
receptors (Gotti and Clementi, 2004; Tribollet et al., 2004), failed to enhance learning of 
a striatum-sensitive maze in which learning is based on egocentric responses. 
Glucose may also selectively modulate α7-mediated signaling processes due to 
the unique functional properties of these receptors. α7 receptors have the highest 
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calcium permeability of any known nicotinic receptor subtype (Castro and Albuquerque, 
1995; Séguéla et al., 1993; Shen and Yakel, 2009). Calcium influx through these 
receptors plays an important role in the presynaptic release of GABA, glutamate, and 
other neurotransmitters in the brain (Shen and Yakel, 2009; Sher et al., 2004; 
Wonnacott et al., 2006). Glucose may potentiate these responses through actions 
mediated by presynaptic ATP-dependent potassium (K-ATP) channels. A number of 
studies indicate that regulation of K-ATP channel activity is important to the memory-
enhancing effects of glucose (Stefani and Gold, 1998, 2001; Stefani et al., 1999; 
Rashidy-Pour, 2001). Another unique property of α7 receptors is that they have a high 
affinity for choline, which functions as a full and selective agonist of these receptors 
(Alkondon et al., 1997; Mike et al., 2000; Uteshev et al., 2003). Glucose may modulate 
the activity of α7 receptors by regulating local extracellular choline levels. Previous 
studies indicate that glucose regulates high-affinity choline uptake and can act 
synergistically to improve memory when administered together with choline (Kopf et al., 
2001; Micheau et al., 1995; Messier et al., 1990). However, the effects of glucose on 
extracellular choline levels, in the context of memory enhancement, have not been 
directly investigated. 
 
5.4.3. Effects of nicotinic antagonists and glucose on CREB activation. 
Intrahippocampal injections of MLA or DHβE reduced pCREB levels in area CA1 
but not the dentate gyrus, perhaps because of insufficient diffusion of the drugs to this 
hippocampal region. Co-administration of glucose reversed DHβE- but not MLA-induced 
pCREB deficits in area CA1, paralleling the behavioral results. The ability of glucose to 
reverse DHβE-induced deficits in pCREB activation supports prior work showing that 
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peripheral glucose or intrahippocampal lactate administration modulates hippocampal 
CREB phosphorylation in the context of memory enhancement (Morris and Gold, 
2012b; Suzuki et al., 2011). Glucose infusions into area CA1 have also been shown to 
activate components of the mTOR pathway while improving memory (Dash et al., 
2006). 
Glucose did not attenuate MLA-induced deficits in pCREB activation in area CA1, 
and levels of pCREB in MLA-injected rats were correlated with individual differences in 
alternation performance. These results support the hypothesis that α7 signaling 
pathways involving CREB activation may be important to the memory-enhancing effects 
of glucose. Previous studies have shown that chronic changes in CREB levels were 
correlated with spatial working memory performance in the radial arm maze (Rendeiro 
et al., 2012; Williams et al., 2008). However, based on the time of drug administration in 
the present study, it is unlikely that the acute changes in CREB phosphorylation could 
initiate transcriptional events quickly enough to alter behavioral performance. More 
likely, CREB activation here serves as a good marker of upstream molecular processes 
that may play a more direct role in modulating spatial working memory processes. 
 
5.4.4. Conclusions. 
The present results indicate that glucose reverses deficits in memory and CREB 
phosphorylation produced by the α4β2 receptor antagonist DHβE but not the α7 
receptor antagonist MLA. The ineffectiveness of glucose at reversing MLA-induced 
deficits in both behavioral and molecular measures suggests that the memory-
enhancing effects of glucose involve its ability to activate downstream α7 receptor 
signaling. Although α4β2 receptors appear to be less important in this regard, the 
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current results do not rule out the possibility that other acetylcholine receptor subtypes 
(e.g. muscarinic receptors) or neurotransmitter systems may also play a role. Given the 
central function of glucose in brain metabolism, it seems likely that glucose modulates 
cognition by multiple mechanisms, perhaps dependent on the interaction of brain area, 
memory task, and other variables. 
 
5.5. FIGURES 
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Figure 5.1. Effects of peripherally-administered nicotinic antagonists on inhibitory avoidance 
memory tested 7 days after training. 
(A) MLA doses of 2 and 5, but not 0.5 mg/kg, significantly impaired memory. (*) ps < .05 vs. 
saline. Ns = 8. (B) DHβE doses of 2 and 5, but not 0.5 mg/kg, significantly impaired memory. (*) 
ps < .05 vs. saline. Ns = 8. 
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Figure 5.2. Glucose attenuation of drug-induced memory impairments after inhibitory avoidance 
training. 
Pre-training administration of MLA or DHβE (2 mg/kg), together with post-training saline 
injections, produced deficits in memory tested at 7 days after training. Post-training glucose 
attenuated the drug-induced memory impairments, but was more effective at reversing the 
impairments induced by DHβE. (*) ps < .05 vs. saline-saline. Ns = 8. 
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Figure 5.3. Effects of peripherally-administered nicotinic antagonists on spontaneous alternation 
spatial working memory scores. 
(A) An MLA dose of 2, but not 0.5 or 5 mg/kg, significantly impaired alternation scores. (*) p < 
.05 vs. saline. Ns = 8. (B) DHβE doses of 2 and 5, but not 0.5 mg/kg, significantly impaired 
alternation scores. (*) ps < .05 vs. saline. Ns = 8. 
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Figure 5.4. Glucose attenuation of drug-induced working memory impairments in the 
spontaneous alternation task. 
MLA or DHβE (2 mg/kg) produced deficits in alternation scores. Co-administration of glucose 
with the antagonists attenuated DHβE but not MLA-induced deficits. (*) ps < .05 vs. saline. Ns = 
8. 
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Figure 5.5. Effects of intrahippocampally-administered nicotinic antagonists on working memory 
assessed in a spontaneous alternation task. 
(A) MLA doses of 6.75 and 13.5, but not 27 µg/side, significantly impaired alternation scores. (*) 
ps < .05 vs. aCSF. N = 9. (B) DHβE doses of 8 and 20, but not 4 µg/side, significantly impaired 
alternation scores. (*) ps < .05 vs. aCSF. N = 9. To the right of each graph is an illustration of 
the infusion sites targeting the dorsal hippocampus for each experiment. Filled circles represent 
tips of infusion tracts. Numbers refer to distance in mm posterior to bregma. Adapted with 
permission from Paxinos and Watson (2005). 
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Figure 5.6. Glucose attenuation of impairments in spontaneous alternation memory scores 
produced by intrahippocampally-administered antagonists. 
MLA (6.75 µg/side) or DHβE (8 µg/side) produced deficits in alternation scores. Co-
administration of glucose with the antagonists attenuated DHβE but not MLA-induced deficits. 
There was a trend for enhancement in alternation scores following administration of glucose 
alone. (*) ps < .05 vs. aCSF. Ns = 8 for aCSF and GLU. Ns = 7 for all other groups. 
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Figure 5.7. Differences in pCREB immunoreactivity in area CA1 following spontaneous 
alternation testing with intrahippocampal administration of drugs. 
(A) MLA (6.75 µg/side) or DHβE (8 µg/side) reduced pCREB levels. Co-administration of 
glucose with the antagonists attenuated DHβE but not MLA-induced pCREB deficits. (*) ps < .05 
vs. aCSF. Ns = 8 for aCSF and GLU. Ns = 7 for all other groups. (B) Representative 
photomicrographs of pCREB immunostaining in area CA1. Scale bar = 100 microns. 
 135 
 
 
 
Figure 5.8. Correlations between area CA1 pCREB immunostaining and spontaneous 
alternation scores. 
There was a significant correlation in rats receiving intrahippocampal injections of MLA-glucose 
(p < .01), and a trend for a correlation in rats receiving MLA alone (p = .09). 
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CHAPTER 6: CONCLUSIONS 
 The main objective of this dissertation was to examine how age-related deficits in 
blood glucose responses to epinephrine could alter central neurobiological processes 
and produce memory impairments. The major hypothesis was that an uncoupling 
between peripheral epinephrine and glucose release in old rats causes memory 
impairments by altering downstream cholinergic signaling processes in the brain. This 
hypothesis, as well as the accompanying model presented in Figures 1.1 and 1.2, was 
supported by a variety of data. 
 Compared to young adult rats, old rats exhibited rapid forgetting in the inhibitory 
avoidance task, which correlated with neurochemical and molecular deficits (Chapters 
2, 3, and 4). In vivo microdialysis measures indicated that old rats had significantly 
reduced hippocampal acetylcholine release at baseline and in response to training. 
Immunohistochemistry measures 30 min after training showed that old rats had 
significantly reduced pCREB levels in the hippocampus and amygdala. The extensive 
age-related depletion in acetylcholine release likely made a large contribution to pCREB 
deficits, even though CREB phosphorylation is downstream of a variety of 
neurotransmitters and growth factors. Post-training glucose injections significantly 
reversed age-related memory impairments while attenuating deficits in hippocampal 
acetylcholine release and CREB phosphorylation. In contrast, post-training epinephrine 
injections were less effective in each of these cases. The greater effectiveness of 
glucose was most likely because it could bypass the age-related uncoupling between 
peripheral epinephrine and glucose release. The only measure at which epinephrine 
was more effective than glucose was at attenuating age-related deficits in CREB 
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phosphorylation in the amygdala. This is likely because epinephrine can stimulate other 
pathways to CREB phosphorylation independent of its effects on blood glucose levels. 
Together, these results suggest that age-related changes in peripheral epinephrine and 
glucose release can alter neural functions, depressing local acetylcholine release and 
changing regional patterns of CREB phosphorylation, perhaps leading to memory 
impairments. 
 Unlike in the other chapters, the experiments in Chapter 5 utilized only young 
adult rats, lacking direct comparisons with old rats. Instead, these experiments 
effectively modeled age-related memory impairments in young rats by injecting them 
with one of two nicotinic acetylcholine receptor antagonists: the α7 receptor antagonist 
MLA or the α4β2 receptor antagonist DHβE. Rats receiving either MLA or DHβE had 
impairments in behavioral and molecular measures similar to those seen in old rats. In 
the inhibitory avoidance task, rats receiving either antagonist had a strong memory of 
the training experience when tested 1-hr but not 7 days later, mimicking age-related 
forgetting. In the spontaneous alternation task, rats receiving either antagonist had 
alternation scores near chance performance, similar to the deficits observed in aged 
rats. In addition, MLA and DHβE produced deficits in hippocampal CREB 
phosphorylation following spontaneous alternation testing. Interestingly, glucose 
injections were much more effective at attenuating the memory and CREB deficits 
induced by DHβE as opposed to those induced by MLA. These results suggest that 
memory enhancement and reversal of age-related memory impairments by glucose 
involve its ability to activate downstream α7 receptor signaling. This hypothesis is 
further supported by data not shown in this dissertation, in which MLA blocked the 
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memory-enhancing effects of glucose in the inhibitory avoidance and spontaneous 
alternation tasks. However, corresponding experiments with DHβE were not completed. 
 Taken together, the studies presented in this dissertation provide a potential 
mechanism for age-related increases in the rate of forgetting (see Figure 1.2). 
According to this model, age-related deficits in blood glucose rises in response to 
endogenous epinephrine release reduce the supply of glucose to particular neural 
systems important for memory. This diminished neuroendocrine response limits 
cholinergic signaling processes, including reducing activation of α7 nicotinic 
acetylcholine receptors. Depressed nicotinic signaling impairs a variety of downstream 
molecular processes, including CREB phosphorylation. Any or all of the deficits along 
this pathway could produce age-related memory impairments. 
 An open question is why blood glucose levels lose their sensitivity to epinephrine 
in old rats. One clue is that old rats actually have higher circulating epinephrine in 
response to training or stress, perhaps representing an impaired physiological 
mechanism in the liver for producing increases in blood glucose levels. This hypothesis 
is supported by evidence that old rats have reduced liver glycogen levels and impaired 
mobilization of glycogen following epinephrine injections compared to young rats. 
However, blood glucose levels are regulated by a number of other hormones, including 
insulin, glucagon, and corticosterone. Evaluating age-related changes in these 
hormones, as well as their interactions in regulating glucose homeostasis, may provide 
greater insight into deficits in blood glucose rises in response to stress or training. 
 Although both epinephrine and glucose support improved memory in old rats, 
glucose appears to be more effective. This is not surprising given that glucose is the 
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primary energy source for the brain under normal physiological conditions. Therefore, 
one strategy for attenuating or reversing age-related cognitive impairments in humans 
may be to administer oral glucose supplements. A number of studies have shown that 
glucose but not the artificial sweetener saccharin improves cognitive functions in elderly 
individuals, particularly on tasks where there are age-related deficits. However, there 
are a variety of potential problems associated with glucose supplementation in elderly 
people. First, glucose only works when it is administered close to the time of cognitive 
testing. In everyday life, it would be difficult to predict the times associated with high 
cognitive demand in which glucose would be most beneficial. Second, a relatively large 
percentage of older individuals have impaired blood glucose regulation, which can be 
comorbid with chronic diseases that produce memory impairments. Administering 
glucose to these individuals could exacerbate chronic conditions and be potentially 
dangerous. Finally, glucose or other carbohydrates eventually broken down into glucose 
are an important part of our diets. Coordinating glucose supplementation with normal 
dietary intake would be complicated, requiring highly compliant patients. 
 Targeting cholinergic signaling, and in particular nicotinic α7 receptors, may be 
another strategy for attenuating or reversing age-related cognitive impairments. 
However, drugs that enhance acetylcholine levels in the brain or that activate specific 
muscarinic or nicotinic acetylcholine receptor subtypes have only been mildly successful 
at treating age-related memory pathologies. Acetylcholinesterase inhibitors remain the 
only class of cholinergic drugs that have significantly improved cognitive, behavioral, 
and other outcome measures in large clinical trials of patients with Alzheimer’s disease. 
Even so, cholinesterase inhibitors are only expected to ―delay worsening of symptoms 
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for 6 to 12 months, on average, for about half the people who take them,‖ according to 
the Alzheimer’s Association. Cholinesterase inhibitors also provide little benefit to 
patients with mild cognitive impairment, which often precedes the development of 
Alzheimer’s disease. The large majority of drugs in development for the treatment of 
Alzheimer’s disease and other age-related memory pathologies target the associated 
inflammation, insulin resistance, or abnormal accumulation of plaques or tangles, rather 
than directly modulating cholinergic signaling processes. 
 Cholinergic drugs are just one example of memory-enhancing agents that have 
shown little effectiveness in treating the symptoms or delaying the progression of 
human memory pathologies. Other such agents include phosphodiesterase inhibitors 
and drugs that target different neurotransmitter systems. The ineffectiveness of these 
pharmacological treatments may relate to the timing of drug administration. These drugs 
are usually administered routinely to achieve more or less constant levels in the brain. 
Similar to the problems associated with chronic glucose administration discussed 
above, this regimen ignores important concepts related to memory modulation, i.e. 
memory enhancing agents work best when administered at or near the time of a 
particular experience. Chronically increasing levels of these drugs may provide some 
benefit, especially in pathologies where there are significant impairments in basal 
functions. However, this could also result in a diminished sensitivity to modulatory 
processes, possibly reducing the durability of newly formed memories.  
 The current trend is to develop memory-enhancing drugs that have more and 
more specific mechanisms of action. For example, a variety of nicotinic α7 receptor 
agonists are currently being developed and tested for the potential treatment of the 
 141 
symptoms of Alzheimer’s disease and related cognitive deficits. This approach may lead 
to fewer side effects and higher therapeutic indices, but is unlikely to produce significant 
memory benefits due to its narrow focus. Memory formation is modulated by multiple 
interconnected or independent pathways and is dependent on the interaction of brain 
area, memory task, and other variables. Agents such as α7 agonists that target specific 
receptor subtypes may show a high degree of efficacy in rodent models because these 
are controlled environments in which relatively subtle changes in memory function can 
be measured. However, these benefits are unlikely to translate into clinical settings. 
 The development of more broad-based treatment strategies may be necessary to 
mitigate age-related memory impairments in humans. Instead of focusing on drugs that 
target very specific pathways, more attention should be given to global modulators of 
memory function, such as peripheral hormones and neuroendocrine systems. The 
results presented in this dissertation suggest that an important component of age-
related memory impairments may be reduced blood glucose responses to epinephrine. 
Therefore, improving the sensitivity of this neuroendocrine response may represent a 
viable strategy for attenuating age-related impairments in memory. 
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